Skip to main content
SpringerLink
Log in
Book cover

Proktologie pp 113–230Cite as

Perianal lokalisierte Krankheitsbilder

  • Chapter

  • 84 Accesses

Zusammenfassung

Die Kenntnis der bevorzugt oder nur gelegentlich im Anal- und/oder Perianalbereich lokalisierten dermatologischen Krankheitsbilder ist Voraussetzung einer differenzierten und damit letztlich befriedigenden proktologischen Arbeit.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  1. Alexander-Williams J (1983) Pruritus ani. extracta dermatologica 5: 433–439

    Google Scholar 

  2. Bernhard JD (1994) Itch: Diagnosis and treatment. McGraw-Hill, New York

    Google Scholar 

  3. Brasch J (1993) Lokalisierter Pruritus. Z Hautkrankht 5: 332–334

    Google Scholar 

  4. Daniel GL, Longo WE, Vernava AM 3rd (1994) Pruritus ani. Causes and concerns. Dis Colon Rectum 37/7: 670–674

    Article  Google Scholar 

  5. Dasan S, Neill SM, Donaldson DR, Scott HJ (1999) Treatment of persistent pruritus ani in a combined colorectal and dermatologic clinic. Br J Surg 86/10: 1337–1340

    Article  Google Scholar 

  6. Denman ST (1986) A review of pruritus. J Am Acad Dermatol 14: 375–392

    Article  PubMed  CAS  Google Scholar 

  7. Giordano M, Rebesco B, Torelli I, Blanco G, Cattarini G (1999) Pruritus ani. Minerva Chir 54/12: 885–891

    Google Scholar 

  8. Greither A (1980) Pruritus und Prurigo. Hautarzt 31: 397–405

    PubMed  CAS  Google Scholar 

  9. Handwerker HO (1993) Neurophysiologische Mechanismen des Juckens. Z Hautkrankht 11: 730–735

    Google Scholar 

  10. Jones DJ (1992) ABC of colorectal diseases. Pruritus ani. BMJ 305/6853: 575–577

    Article  Google Scholar 

  11. Laurent A, Boucharlat J, Bosson JL, Derry A, Imbert R (1997) Psychological assessment of patients with idiopathic pruritus ani. Psychother Psychosom 66/3: 163–166

    Article  Google Scholar 

  12. Lyell A (1972) The itching patient. Scot Med J 17: 334

    PubMed  CAS  Google Scholar 

  13. Marghescu S (1993) Pruritus sine materia. Z Hautkrankht 5: 335–337

    Google Scholar 

  14. Mauß J (1985) Pruritus ani. Dtsch Arztebl 54: 2726–2730

    Google Scholar 

  15. Pfenninger JL, Zainea GG (2001) Common anorectal conditions: Part 1. Symptoms and complaints. Am Fam Physician 63/12: 2391–2398

    Google Scholar 

  16. Steen KH et al. (1995) Die neuronale Vermittlung des Pruritus. Z Hautkrankht 1: 43–47

    Google Scholar 

  17. Steigleder GK (1986) Zur Differenzialdiagnose des Pruritus. Z Hautkrankht 12: 839

    Google Scholar 

  18. Amiry SA, Pride HB, Tyler WB (2001) Perianal pseudoverrucose papules and nodules mimicking condylomata acuminata and child sexual abuse. Cutis 67/4: 335–338

    Google Scholar 

  19. Altmeyer P (1973) Die Bedeutung tluorierter Glukokortikoide in der Aetiopathogenesis des Granuloma glutaeale infantum. Z Hautkrankht 48: 621–626

    Google Scholar 

  20. Bruckner-Tuderman L (1984) Granuloma glutaeale infantum. Hautarzt 37: 347–349

    Google Scholar 

  21. Drake LA, Dinehart SM, Farmer ER et al. (1996) Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol 35/4: 615–619

    Google Scholar 

  22. Gysler A, Schafer-Korting M (2001) Glukokortikoide. In: Korting HC, Sterry W (Hrsg) Therapeutische Verfahren in der Dermatologie: Dermatika und Kosmetika. Blackwell, Berlin, S 10 1–111

    Google Scholar 

  23. Jacobs JA, Kolbach DN, Vermeulen AH, Smeets MH, Neumann HA (2001) Tinea incognito due to Trichophytom rubrum after local steroid therapy. Clin Infect Dis 33/12: E142–144

    Article  Google Scholar 

  24. Maekawa Y, Sakazaki Y, Hayashibara T (1978) Diaper area granuloma of the aged. Arch Dermatol 114/3: 382–383

    Article  Google Scholar 

  25. Raimer SS (2001) The safe use of topical corticosteroids in children. Pedriatr Ann 30/4: 225–229

    Google Scholar 

  26. Rodriguez Cano L, Gracia-Patos Briones V, Pedragosa Jove R, Castells Rodellas A (1994) Perianal pseudoverrucous papules and nodules after surgery of Hirschsprung disease. J Pedriatr 126/6: 914–916

    Article  Google Scholar 

  27. Solomon BA, Glass AT, Rabbin PE (1996) Tinea incognito and „over-the-counter“ potent topical steroids. Cutis 58/4: 295–296

    Google Scholar 

  28. Stein E (1974) Uncharakteristische dermatologische Krankheitsbilder durch Korikosteroid-KombinationsExterna. Anti Praxis 14: 613

    Google Scholar 

  29. Stein E (1976) Ursachen perianaler Hautaffektionen. Anti Praxis 90: 3526

    Google Scholar 

  30. Tappeiner J, Ptleger L (1971) Granuloma glutaeale infantum. Hautarzt 22: 383–388

    PubMed  CAS  Google Scholar 

  31. Zeeuw R de, Praag MC van, Oranje AP (2000) Granuloma gluteale infantum: a case report. Pedriatr Dermatol 17/2: 141–143

    Article  Google Scholar 

  32. Andersen KE, Hjorth N, Menne T (1984) The baboon syndrome-systematically induced allergic contact dermatitis. Contact Dermatitis 10: 97–100

    Article  PubMed  CAS  Google Scholar 

  33. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2000) Leitlinie zum Krankheitsbild des Analekzems. Leitlinien der Deutschen Dermatologischen Gesellschaft. AMWF online, awmf@uni-duesseldorf.de

    Google Scholar 

  34. Bauer A, Geier J, Elsner P (2000) Allergic contact dermatitis in patients with anogenital complaints. J Reprod Med 45/8: 649–654

    Google Scholar 

  35. Blecher P, Korting HC (1992) Gesteigertes Risiko fUr Analekzeme durch Recycling-Hygienepapier? Dermatologie 6:5

    Google Scholar 

  36. Blecher P, Korting HC (1995) Tolerance to different toilet paper preparations: toxicological and allergological aspects. Dermatology 191/4: 299–304

    Article  Google Scholar 

  37. Groot AC de, Baar TJ, Terpstra H, Weyland JW (1991) Contact allergy to moist toilet paper. Contact Dermatitis 24/2: 135–136

    Article  Google Scholar 

  38. Herfs H, Schirren CG, Przybilla B, Plewig G (1993) Das „Baboon-Syndrom“. Hautarzt 44: 466–469

    PubMed  CAS  Google Scholar 

  39. Hornstein OP (1984) Ekzemkrankheiten. Therapiewoche 34: 400–409

    Google Scholar 

  40. Hornstein OP (1986) Anmerkungen und Vorschlage zur Definition und Klassifikation der Ekzemkrankheiten. Z Hautkrankht 61: 18, 1281–1296

    CAS  Google Scholar 

  41. Kearney CR, Fewings J (2001) Allergic contact dermatitis to cinchocaine. Australas J Dermatol 4212: 118–119

    Article  Google Scholar 

  42. Lazarov A (1999) Perianal contact dermatitis caused by nail lacquer allergy. Am J Contact Dermat 10/1: 43–44

    Article  Google Scholar 

  43. Lechner T, Grytzmann B, Baurle G (1987) Hamatogenes allergisches Kontaktekzem nach oraler Gabe von Nystatin. Mykosen 30: 143–146

    Article  PubMed  CAS  Google Scholar 

  44. Montag G, Weber L, Gall H (1996) Baboon-Syndrom auf Allopurinol. Aktuel Dermatol22: 311–313

    Google Scholar 

  45. Oostendorp I, Rakoski J (1991) Kontaktekzeme in der Analregion. Der Dtsch Dermatologe 39: 1317–1318

    Google Scholar 

  46. Peters K-P, Lechner T, Grytzmann B (1987) Perianal auftretende Arzneimittelreaktionen. In: Forstmann P, SchUler H, Alpers R (Hrsg) Aktuelle Koloproktologie, Bd 4. Edition Nymphenburg, Miinchen

    Google Scholar 

  47. Rietschel RL, Fowler JF (eds) (2001) Fisher's contact dermatitis, 5th edn. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  48. Ring J (1996) Zum Wandel des Ekzem-Begriffes: Klassisches versus atopisches Ekzem. Hautkrankht 10: 752–756

    Google Scholar 

  49. Rycroft RJG, Menne T, Frosch PJ (eds) (2001) Textbook of contact dermatitis, 3rd edn. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  50. Stein E (1973) Kritische Betrachtung zur Anwendung von Cortikosteroid-Kombinations-Externa (CKE) bei Hautkrankheiten. Z Allgemeinmed 26: 1227–1233

    Google Scholar 

  51. Stein E (1994) Perianalekzem. Chir Gastroenterol 10: 299–302

    Article  Google Scholar 

  52. Waldmann T, Ponnighaus JM, Kowalzick L (1999) Baboon-Syndrom durch Amoxicillin. Akt Dermatol 25: 73–75

    Google Scholar 

  53. Weiss JM, Mockenhaupt M, Schöpf E, Simon JC (2001) Fixes Arzneimittelexanthem auf Terbinafin mit charakteristischem Verteilungsmuster eines Baboon-Syndroms. Hautarzt 52: 1104–1106

    Article  PubMed  CAS  Google Scholar 

  54. Bolognia JL, Pawelek JM (1988) Biology of hypopigmentation. J Am Acad Dermatol1912:217–255

    Google Scholar 

  55. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  56. Geel N van, Ongenae K, Naeyaert JM (2001) Surgical techniques for vitiligo. Dermatology 202/2: 162–166

    Article  Google Scholar 

  57. Iliev D, Elsner P (1998) An unusual hypopigmentation in occupational dermatology: presentation of a case and review of the literature. Dermatology 196/2: 248–250

    Article  Google Scholar 

  58. Le Poole C, Boissy RE (1997) Vitiligo. Semin Cutan Med Surg 16/1: 3–14

    Article  Google Scholar 

  59. Lerner EA, Sober AJ (1988) Chemical and pharmacologic agents that cause hyperpigmentation or hypopygmentation of the skin. Dermatol Clin 6/2: 327–337

    Google Scholar 

  60. Malakar S, Panda S (2001) Post-inflammatory depigmentation following allergic contact dermatitis to chloroxylenol. Br J Dermatol144/6: 1275–1276

    Article  Google Scholar 

  61. Nordlund JJ, Abdel-Malek ZA (1988) Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation. Prog Clin Biol Res 256: 219–236

    PubMed  CAS  Google Scholar 

  62. Pandya AG, Guevara IL (2000) Disorders of pigmentation. Dermatol Clin 1811: 91–98

    Google Scholar 

  63. Shaffrali F, Gawkrodger D (2000) Management of vitiligo. Clin Exp Dermatol 25/8: 575–579

    Article  Google Scholar 

  64. Westerhof W (2000) Vitiligo management update. Skin Therapy Lett 5/6: 1–2,5

    Google Scholar 

  65. Alexander SJ (1979) Squamous cell carcinoma in chronic hydradenitis suppurativa. A case report. Cancer 43: 745–748

    Article  PubMed  CAS  Google Scholar 

  66. Attanoos RL, Appleton MA, Douglas-Jones AG (1995) The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 133/2: 254–258

    Article  Google Scholar 

  67. Bellomo R (1990) Chirurgische Behandlung des Morbus Verneuil. Coloproctology 1: 50–53

    Google Scholar 

  68. Black SB, Woods JW (1982) Squamous cell carcinoma complicating hydradenitis suppurativa. J Surg Oncol 19: 25–26

    Article  PubMed  CAS  Google Scholar 

  69. Bierl H (1995) Differenzierte Akne-Therapie mit hoher Erfolgsquote. TW Dermatol 25: 239–242

    Google Scholar 

  70. Boer J, Weltevreden EF (1996) Hidradenitis suppurativa or acne inversa. A clinicopathologic study of early lesions. Br J Dermatol135/5: 721–725

    Article  Google Scholar 

  71. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  72. Breuninger H, Wienert H (2001) Acne inversa. Dtsch Arztbl 98/44: C2293

    Google Scholar 

  73. DiGiovanna JJ (2001) Systemic retinoid therapy. Dermatol Clin 19/1: 161–167

    Google Scholar 

  74. Fanta D, Messeritsch-Fanta C (1999) Akne 1999: brauchen wir den Hautarzt noch? Hautarzt 50: 900–911

    Article  PubMed  CAS  Google Scholar 

  75. Hartschuh W (1997) Acne inversa (Pyodermia fistulans sinifica). Coloproctology Verbandsnachrichten 19/1: 9–13

    Google Scholar 

  76. Jansen T, Romiti R, Plewig G (2000) Acne fulminans. Schwere Akne mit ungewohnlichem klinischem Verlauf. Dtsch Arzteb197/22: A1533–A1537

    Google Scholar 

  77. Jemec GB, Faber M, Gutschik E, Wendelboe P (1996) The bacteriology of hidradenitis suppurativa. Dermatology 193/3: 203–206

    Article  Google Scholar 

  78. Jemec GB, Heidenheim M, Nielsen NH (1996) The prevalence of hidradenitis suppurativa and its potential precursor lesions. JAm Acad Dermatol 35/2: 191–194

    Article  Google Scholar 

  79. Jemec GB, Thomsen BM, Hansen U (1997) The homogeneity of hidradenitis suppurativa lesions. A histological study of intra-individual variation. APMIS 105/5: 378–383

    Article  Google Scholar 

  80. Kaufer C, Axnick E (1988) Operative Therapie der Aknetetrade. Z Hautkrankht 63/7: 597–609

    Google Scholar 

  81. Kreißler-Haag D et al. (1994) Die mehrzeitige chirurgische Samerung der schweren perianalen und perigenitalen Pyodermien. Coloproctology 6: 371–374

    Google Scholar 

  82. Küster W, Rodder-Wehrmann O, Plewig G (1991) Acne inversa. Pathogenese und Genetik.Hautarzt 4211: 2–4

    Google Scholar 

  83. Kurzen H, Schönfelder-Funcke S, Hartschuh W (2000) Surgical treatment of acne inversa at the University of Heidelberg. Coloproctology 22: 76–80

    Article  Google Scholar 

  84. Lentner A (1995) Pyoderma fistulans sinifica (Acne inversa). H + G 70: 460

    Google Scholar 

  85. Lentner A, Rübben A, Wiener V (1992) Klinisches Erscheinungsbild und Therapie der Pyodermia fistulans sinifica (Acne inversa). Z Hautkrankht 67: 988–992

    Google Scholar 

  86. Michalowski R (1973) Akne conglobata mit spinozellularem Karzimnom. Hautarzt 24: 404

    PubMed  CAS  Google Scholar 

  87. National Dermatology Working Group (1997) Isotretino in (roaccutane) usage-a South African consensus guideline. S Afr Med J 87110: 1410–1413

    Google Scholar 

  88. Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  89. Plewig G (1983) Die sogenannten rezidivierenden SchweiBdrUsenabszesse und ihre chirurgische Behandlung. In: Schweiberer L (Hrsg) Chirurgische und plastisch-chirurgische Aspekte bei Infektionen und infizierten Defekten der Korperoberflache, der Extremitaten und der Analregion. Zuckschwert, MUnchen Bern Wien

    Google Scholar 

  90. Plewig G, Steger M (1989) Acne inversa. In: Marks R, Plewig G (eds) Acne and related disorders. Martin Dunitz, London

    Google Scholar 

  91. Quintal D, Jackson R (1986) Aggressive squamous cell carcinoma arising in familial acne conglobata. J Am Acad Dermatol 14:207–214

    Article  PubMed  CAS  Google Scholar 

  92. Rodder-Wehrmann O, Kuster W, Plewig G (1991) Acne inversa. Diagnose und Therapie. Hautarzt 4211: 5–8

    Google Scholar 

  93. Rompel R, Petres J (1995) Operative Akne-Therapie. H+G 70: 700–704

    Google Scholar 

  94. Verneuil A (1864) De l'hidrosadénite phlegmoneuse et des abces sudoripares. Arch Gen Med 114: 537–557

    Google Scholar 

  95. Verneuil A (1865) De l'hidrosadenite phlegmoneuse et des abces sudoripares. Arch Gen Med 115: 327–337

    Google Scholar 

  96. Verneuil A (1865) De hidrosadenite phlegmoneuse et des abces sudoripares. Arch Gen Med 115: 437–453

    Google Scholar 

  97. Wienert V, Breuninger H, Müller RPA (2001) Acne inversa. In: Korting HC, Callies R, Reusch M, Schlaeger M, Schöpf E, Sterry W (Hrsg) Dermatologische Qualitatssicherung-Leitlinien und Empfehlungen, 2. Aufl. Zuckschwerdt, MUnchen, S 32–39

    Google Scholar 

  98. Abboud B, Ingea H (1999) Recurrent squamous-cell carcinoma arising in sacrococcygeal pilonidal sinus tract: report of a case and reviwe of the literature. Dis Colon Rectum 42/4: 525–528

    Article  Google Scholar 

  99. AI-Hassan HK, Francis IM, Neglen P (1990) Primary closure or secundary granulation after excision of pilonidal sinus? Acta Chir Scand 156/10: 695–699

    Google Scholar 

  100. Anderson AW (1847) Hair extracted from an ulcer. Boston Med Surg 36: 74–76

    Google Scholar 

  101. Benhamou G, Vilotte J (1988) Kystes et sinus pilonidaux. Ann Dermatol Venerol 115: 95–97

    CAS  Google Scholar 

  102. Bock J-U et al. (1995) Therapie des Sinus pilonidalis. T W Dermatologie 25: 210–215

    Google Scholar 

  103. Buchmann P (1994) Lehrbuch der Proktologie, 3.Aufl. Huber, Bern

    Google Scholar 

  104. Dahl HD, Henrich MH (1992) Licht-und elektronenmikroskopische Untersuchungen zur Pathogenese des Sinus pilonidalis und der Analfistel. Langenbecks Arch Chir 377: 118–124

    Article  PubMed  CAS  Google Scholar 

  105. Davis KA, Mock CN, Versaci A, Lentrichia P (1994) Malignant degeneration of pilonidal cysts. Am Surg 60/3: 200–204

    Google Scholar 

  106. Denkers D, Girona J (1996) Der abszedierte Sinus pilonidalis der SteiBbeinregion-Moglichkeiten der chirurgischen Versorgung. Coloproctology 6:257–259

    Google Scholar 

  107. Fuzun M et al. (1994) Which technique for treatment of pilonidal sinus-open or closed? Dis Colon Rectum 37: 1148–1150

    Article  PubMed  CAS  Google Scholar 

  108. Giebel D, Menningen R, Petrovici V (1994) Transpositionslappen bei der Behandlung des Sinus pilonidalis. Coloproctology 4: 255–262

    Google Scholar 

  109. Hodges RM (1889) Pilonidal sinus. Boston Med Surg J 103:485

    Article  Google Scholar 

  110. Hodgkin W (1998) Pilonidal sinus disease. J Wound Care. 7/9: 481–483

    Google Scholar 

  111. Khaira HS, Brown JH (1995) Excision and primary suture of pilonidal sinus. Ann R ColI Surg 77: 242–244

    CAS  Google Scholar 

  112. Kooistra HP (1942) Pilonidal sinuses: review of the literature and report of three hundred and fifty cases. Am J Surg 55: 3

    Article  Google Scholar 

  113. Kulayat MN, Gong M, Doerr RJ (1996) Multimodality treatment of squamous cell carcinoma complicating pilonidal disease. Am Surg 62/11: 922–929

    Google Scholar 

  114. Marks J et al. (1985) Pilonidal sinus excision-healing by open granulation. Br J Surg 72: 637–640

    Article  PubMed  CAS  Google Scholar 

  115. Philipshen SJ, Gray G, Goldsmith E, Dineen P (1981) Carcinoma arising in pilonidal sinuses. Ann Surg 193/4: 506–512

    Google Scholar 

  116. Schneider IH, Thaler K, Kockerling F (1994) Treatment of pilonidal sinuses by phenol injections. Int J Colorectal Dis 9/4: 200–202

    Article  Google Scholar 

  117. Silva JH da (2000) Pilonidal cyst: cause and treatment. Dis Colon Rectum 43/8: 1146–1156

    Article  Google Scholar 

  118. Spivak H, Brooks VL, Nussbaum M, Friedman I (1996) Treatment of chronic pilonidal disease. Dis Colon Rectum 39/10: 1136–1139

    Article  Google Scholar 

  119. Sondenaa K et al. (1992) Morbidity and short term results in a randomised trial of open compared with closed treatment of chronic pilonidal sinus. Eur J Surg 158: 351–355

    PubMed  CAS  Google Scholar 

  120. Sondenaa K et al. (1995) Bacteriology and complications of chronic pilonidal sinus treated with excision and primary suture. Int J Colorect Dis 10: 161–166

    Article  CAS  Google Scholar 

  121. Wienert V, Mlitz H, Prinz B (2001) Pilonidalsinus. In: Korting HC, Callies R, Reusch M, Schlaeger M, Schöpf E, Sterry W (Hrsg) Dermatologische Qualitatssicherung-Leitlinien und Empfehlungen, 2. Aufl., Zuckschwerdt, Miinchen, S 40–45

    Google Scholar 

  122. Abeck D, Mempel M, Seidl HP, Schnopp C, Ring J, Heeg K (2000) Impetigo contagiosa-Erregerspektrum und therapeutische Konsequenzen. Dtsch Med Wschr 125: 1257–1259

    Article  PubMed  CAS  Google Scholar 

  123. Abeck D, Strom K, Schnopp C, Korting HC, Heeg K (2001) Pyodermien-Ein interdisziplinares Problem. Dtsch Arztebl 98/45: C2338ff.

    Google Scholar 

  124. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  125. Darmstadt GL, Lane AT (1994) Impetigo: an overview. Pediatr Dermatol 11: 294–303

    Google Scholar 

  126. Korting HC, Neubert U, Abeck D (1998) Current antimicrobial susceptibility of cutaneous bacteria to first line antibiotics. Int J Antimicrob Agents 10:165–168

    Article  PubMed  CAS  Google Scholar 

  127. Ochsendorf FR, Richter T, Niemczyk UM, Schafer V, Brade V, Milbradt R (2000) Prospektive Erfassung wichtiger bakterieller Erreger von Pyodermien und deren Invitro-Antibiotikaempfindlichkeit. Hautarzt 51:319–326

    Article  PubMed  CAS  Google Scholar 

  128. Amren DP, Anderson AS, Wannamaker LW (1966) Perianal cellulitis associated with group A streptococci. Am J Dis Child 112/6: 546–552

    Google Scholar 

  129. Heidelberger A, Cremer H, Ring J, Abeck D (2000) Perianale streptogene Dermatitis. Hautarzt 5112: 86–89

    Google Scholar 

  130. Kokx NP, Comstock JA, Facklam RR (1987) Streptococcal perianal disease in children. Pediatrics 80/5: 659–663

    Google Scholar 

  131. Krol AL (1990) Perianal streptococcal dermatitis. Pediatr Dermatol 7/2: 97–100

    Article  Google Scholar 

  132. Mogielnicki NP, Schwartzmann JD, Elliott JA (2001) Perineal group A streptococcal disease in a pediatric practice. Pediatrics 10612: 276–281

    Google Scholar 

  133. Montemarano AD, James WD (1993) Staphylococcus aureus as a cause of perianal dermatitis. Pediatr Dermatol 10/3: 259–262

    Article  Google Scholar 

  134. Neri I, Bardazzi F, Marzaduri S, Patrizi A (1996) Perianal streptococcal dermatitis in adults. Br J Dermatol 135/5: 796–798

    Article  Google Scholar 

  135. Patrizi A, Costa AM, Fiorillo L, Neri I (1994) Perianal streptococcal dermatitis associated with guttate psoriasis and/or balanoposthitis: a study of five cases. Pediatr Dermatol11/2: 168–171

    Article  Google Scholar 

  136. Souillet AL, Truchot F, Jullien D, Dumas V, Faure M, Floret D, Claudy A (2000) Anite perianale streptococcique. Arch Pediatr 7/11: 1194–1196

    Article  Google Scholar 

  137. Allen S, Christmas TI, McKinney W, Parr D, Oliver GF (1990) The Auckland skin clinic tinea pedis and erythrasma study. N Z Med 103/896: 391–393

    Google Scholar 

  138. Golledge CL Phillips G (1991) Corynebacterium minutissimum infection. J Infect 2311:73–76

    Article  Google Scholar 

  139. Mattox TF, Rutgers J, Yoshimori RN, Bhatia NN (1993) Nonfluorescent erythrasma of the vulva. Obstet Gynecol 8115:862–864

    Google Scholar 

  140. Wharton JR, Wilson PL, Kincannon JM (1998) Erythrasma treated with single-dose clarithromycin. Arch Dermatol134/6: 671–672

    Article  Google Scholar 

  141. Bonifaz A, Saul A (2000) Comparative study between terbinafine 1 % emulsion-gel versus ketoconazole 2 % cream in tinea cruris and tinae corporis. Eur J Dermatol1O/2: 107–109

    Google Scholar 

  142. Gupta AK, Einarson TR, Summerbell RC, Shear NH (1998) An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs 55/5: 645–674

    Article  Google Scholar 

  143. Hay RJ (1999) New developments in antifungals. Int J Dermatol 38 (Supp12): 65–69

    PubMed  Google Scholar 

  144. Heerden JS van, Vismer HF (1997) Tinea corporis/cruris: new treatment options. Dermatology 194 (Suppll): 14–18

    Article  PubMed  Google Scholar 

  145. Hoog GS de, Guarro J (Hrsg.) (1995) Atlas of clinical fungi. Centraalbureau voor Schimmelcultures Baarn/ Delft, NL

    Google Scholar 

  146. Korting HC, Abeck D, Bernhardt HI et al. (2001) Tinea der freien Haut. In: Korting HC, Callies R, Reusch M, Schlaeger M, Schöpf E, Sterry W (Hrsg) Dermatologische Qualitatssicherung-Leitlinien und Empfehlungen, 2. Aufl. Zuckschwerdt, Miinchen, S 55–58

    Google Scholar 

  147. Keyser P de, Backer M de, Massart DL, Westelinck KJ (1994) Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study. Br J Dermatol 130 (Supp143): 22–25

    Article  PubMed  Google Scholar 

  148. Silva-Tavares H, Alchorne MM, Fischman O (2001) Tinea cruris epidemiology (Sao Paulo, Brazil). Mycopathologia 149/3: 147–149

    Article  Google Scholar 

  149. Stein E (1995) Diseases of the anus and perianal region. In: Demis DJ (ed) Clinical dermatology, 22. Revision, Vol 4. Lippincott-Raven, Philadelphia New York, pp 1–21

    Google Scholar 

  150. Stein E (1996) Anale Hauterkrankungen: Dermatophytosen. Coloproctology 3: XIII–XVI

    Google Scholar 

  151. Baker DA (1994) Long-term suppressive therapy with acyclovir for recurrent genital herpes. J lnt Med Res 22 (Suppll). 24A–31A

    Google Scholar 

  152. Bratzke B, Orfanos CE, Stavermann T, Ehlers G (1991) Chronisch-erosiver, therapierefraktarer perianaler Herpes (TypII) mit Herpes-Proktitis bei AIDS. Hautarzt 42/2: 96–100

    Google Scholar 

  153. Braun R, Kirchner H (1986) Klinische Bedeutung von lnfektionen mit Herpes-simplex-Viren. Dtsch Arztebl 37/83: 2433–2438

    Google Scholar 

  154. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  155. Gilbert J, Drehs MM, Weinberg JM (2001) Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection. Arch Dermatol137/8: 1015–1017

    Google Scholar 

  156. Doerr HW, Rabenau H (1996) Dermatotrope Herpesviren, lnfektionsbiologie, Epidemiologie und Diagnostik. Chemotherapie J 1: 1–11

    Google Scholar 

  157. Fleming DT, McQuillan GM, Johnson RE et al. (1997) Herpes simplex type 2 in the United States, 1976 to 1994. N Eng J Med 337: 1105–1111

    Article  CAS  Google Scholar 

  158. Glosch St (1996) Herpes-simplex-Virus-lnfektionen. Derm 2: 474–480

    Google Scholar 

  159. Goldmeier D (1980) Proctitis and herpes simplex virus in homosexual men. Br J Vener Dis 56: 111–114

    PubMed  CAS  Google Scholar 

  160. Goodell SE et al. (1983) Herpes simplex virus proctitis in homosexual men. N Engl J Med 308: 868–87l

    Article  PubMed  CAS  Google Scholar 

  161. Gross G (1994) Herpes genitalis. Wegbereiter fUr eine HIV-Ubertragung. TW Dermatologie 24: 150–155

    Google Scholar 

  162. Gross G (1995) Klinik und Therapie der HSV1 und HSV2 lnfektion. In: Ring J, Zander AR, Malin J-p (Hrsg) Diagnostik und Therapie von Herpes Virus-Infektionen. Braun, S 41–62

    Google Scholar 

  163. Lautenschlager S, Eichmann A (2001) The heterogenous clinical spectrum of genital herpes. Dermatology 202/3: 211–219

    Article  Google Scholar 

  164. Lautenschlager S, Kempf W (2000) Herpes genitalis. Hautarzt 51:964–983

    Article  PubMed  CAS  Google Scholar 

  165. Mahler V, Schuler G (2001) Therapie von VarizellaZoster-und Herpes-simplex-Virus-bedingten Erkrankungen. Teil 1: Virustatische Agenzien. Hautarzt 52: 464–471

    Article  PubMed  CAS  Google Scholar 

  166. Mahler V, Schuler G (2001) Therapie von Varizella-Zoster-und Herpes-simplex-Virus-bedingten Erkrankungen. Teil 2: Hinweise zur DurchfUhrung und Indikationen zur virustatischen Therapie. Hautarzt 52: 554–574

    Article  PubMed  CAS  Google Scholar 

  167. McKeough MB, Spruance SL (2001) Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection. Arch Dermatol137/9: 1153–1158

    Google Scholar 

  168. Mindel A (1989) Herpes simplex virus. Springer, London Berlin Heidelberg New York Paris Tokyo

    Book  Google Scholar 

  169. Mindel A et al. (1988) Dosage and safety of long-term suppressive aciclovir therapy for recurrent genital herpes. Lancet I/8591: 926–928

    Article  Google Scholar 

  170. Nahass GT, Goldstein BA, Zhu WY, Serfling U, Penneys NS, Leonardi CL (1992) Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infection. JAMA 268/18: 2541–2544

    Article  Google Scholar 

  171. Moseley RC, Corey L, Benjamin D, Winter C, Remington ML (1981) Comparison of viral isolation, direct immunofluorescence, and direct immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol 13/5: 913–918

    Google Scholar 

  172. Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  173. Petersen EE, Doerr HW, Gross G, Petzoldt D, Weiss enbacher ER, Wutzler P (1999) Der Herpes genitalis. Dtsch Arztebl 38: A2358–A2364

    Google Scholar 

  174. Preiser W, Berger A, Doerr HW (2000) Therapie viraler Erkrankungen. Dtsch Arztbl 50: A3433–A3440

    Google Scholar 

  175. Reimlinger St, Wassilew S (1984) Primarer Herpes analis. Der Hautarzt 35: 263–264

    CAS  Google Scholar 

  176. Rufli Th (1983) Sexuell iibertragene anorektale Infektionskrankheiten. Schweiz Rundschau Med (Praxis) 72: 1000–1008

    CAS  Google Scholar 

  177. Samarasinghe PL, Oates IK, MacLennan IPB (1979) Herpetic proctitis and sacral radiculomyelopathy-a hazard for homosexual man. Br Med J II: 360–365

    Google Scholar 

  178. Schmitt SL, Wexner SD, Nogueras JJ, Jagelmann DG (1993) Is aggressive management of perianal ulcers inhomosexual HIV-positive men justified? Dis Colon Rectum 36/3: 240–246

    Article  Google Scholar 

  179. Stary A (1985) Neuere diagnostische Methoden beim Herpes simplex. Z Hautkrankht 60/22: 1767–1779

    Google Scholar 

  180. Wehr A (1997) Herpes genitalis-die unterschatzte Erkrankung? Beilage in Der Hautarzt 48/1: 1–8

    Google Scholar 

  181. Winceslaus J, Jones PA (1997) Genital herpes masquerading as anal fissures. J R Coli Surg Edinb 42/4: 276–277

    Google Scholar 

  182. Wolf MH (1986) Herpes simplex-Virus-Infektion. Diagnose Labor 36: 104–111

    Google Scholar 

  183. Zimmer D (1995) Herpes genitalis: Emotionale Unterstiitzung bessert Lebensqualitat. Fortschr Med 113/19: 44

    Google Scholar 

  184. Christian CW, Singer ML, Crawford JE, Durbin D (1997) Perianal herpes zoster presenting as suspected child abuse. Pediatrics 99/4: 608–610

    Article  Google Scholar 

  185. Degreef H. et al. (1994) Famciclovir, a new oral antiherpes drug: results of the first controlled chemical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Antimicrobiology Agents Internat 4: 241–246

    Article  CAS  Google Scholar 

  186. Eis-Hübinger AM et al. (1992) Nachweis von VarizellaZoster-Virus-Infektionen mittels Polymerasekettenreaktion. Hautarzt 43: 767–771

    PubMed  Google Scholar 

  187. Engst R (1989) Therapie des Zoster. Z Hautkrankht 64: 848–850

    CAS  Google Scholar 

  188. Gross G (1997) Zoster-Manifestationsformen an der Haut, Komplikationen und Therapie. Dtsch Med Wochenschr 122: 132–139

    Article  PubMed  CAS  Google Scholar 

  189. Jellinek EH, Selby Tulloch W (1976) Herpes zoster with dysfunction of bladder and anus. Lancet 2: 1219–1222

    Article  PubMed  CAS  Google Scholar 

  190. Jucgla A, Badell A, Ballesta C, Arbizu T (1996) Colonic pseudo-obstruction: a complication of herpes zoster. Br J Dermatol134/4: 788–790

    Article  Google Scholar 

  191. Kint A (1987) Neuere therapeutische Moglichkeiten bei Herpes simplex und Herpes zoster. Aktuel Dermatol 13: 241–242

    Google Scholar 

  192. Kempf W, Lautenschlager S (2001) Infektionen mit dem Varizella-zoster-Virus. Hautarzt 52: 359–376

    Article  PubMed  CAS  Google Scholar 

  193. Mahler V, Schuler G (2001) Therapie von VarizellaZoster-und Herpes-simplex-Virus-bedingten Erkrankungen. Teil 1: Virustatische Agenzien. Hautarzt 52: 464–471

    Article  PubMed  CAS  Google Scholar 

  194. Mahler V, Schuler G (2001) Therapie von VarizellaZoster-und Herpes-simplex-Virus-bedingten Erkrankungen. Teil 2: Hinweise zur Durchftihrung und Indikationen zur virustatischen Therapie. Hautarzt 52:554–574

    Article  PubMed  CAS  Google Scholar 

  195. Menuck LS et al. (1976) Colonic Changes of Herpes Zoster. AJR 127:273–276

    PubMed  CAS  Google Scholar 

  196. Nahass GT, Goldstein BA, Zhu WY, Serfling U, Penneys NS, Leonardi CL (1992) Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infection. JAMA 268/18: 2541–2544

    Google Scholar 

  197. Pue MA, Benet LZ (1993) Pharmacokinetics of famciclovir in man. Antiviral Chern Chemother 4 [Suppl] 1

    Google Scholar 

  198. Rowbotham MC (1992) Treatment of postherpetic neuralgia. Semin Dermatol 3: 218–225

    Google Scholar 

  199. Sauerbrei A, Sommer M, Wutzler P (1999) Virologische Diagnostik des Herpes zoster. Hautarzt 50: 873–878

    Article  PubMed  CAS  Google Scholar 

  200. Soltz-Szotz J (1987) 3 Jahre Erfahrung in der Zostertherapie mit Aciclovir und Corticosteroiden. Aktuel Dermatol 13: 245–246

    Google Scholar 

  201. Yamanashi T, Yasuda K, Sakakibara R, Hattori T, Uchiyama T, Minamide M, Ito H (1998) Urinary retention due to herpes virus infections. Neururol Urodyn 17/6: 613–619

    Google Scholar 

  202. Wood MJ et al. (1994) A randomized trial of aciclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 330: 896–900

    Article  PubMed  CAS  Google Scholar 

  203. Bunney MH (1969) Molluscum contagiosum of the sole: A rare diagnosis or a rare condition. Br J Dermatol 81: 623–625

    Article  PubMed  CAS  Google Scholar 

  204. Barba AR, Kapoor S, Berman B (2001) An open label safety study of topical imiquimod 5 % cream in the treatment of molluscum contagiosum in children. Dermatol Online J 7/1: 20

    Google Scholar 

  205. Calista D (2000) Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study. J Eur Acad Dermatol Venereol 14/6: 484–488

    Article  Google Scholar 

  206. Diven DG (2001) An overview of poxiviruses. J Am Acad Dermatol4411:1–16

    Article  Google Scholar 

  207. Epstein E (2001) Cantharidin therapy for molluscum contagiosum in children. J Am Acad Dermatol 45/4: 638

    Article  Google Scholar 

  208. Hammes S, Greve B, Raulin C (2001) Mollusca contagiosa. Hautarzt 52: 38–42

    Article  PubMed  CAS  Google Scholar 

  209. Hawley TG (1970) The natural history of molluscum contagiosum in Fijian children. II. Hyg Camb 68: 631–632

    Article  CAS  Google Scholar 

  210. Hengge UR, Esser S, Schultewolter T, Behrendt C, Meyer T, Stockfleth E, Goos M (2000) Self-administered topical 5 % imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 143/5: 1026–1031

    Article  Google Scholar 

  211. Hicks CB, Myers SA, Giner J (1997) Resolutiion of intractable molluscum contagiosum in a human immunodeficiency virus-infected patient after institution of antiretroviral therapy with ritonavir. Clin Infect Dis 24/5: 1023–1025

    Article  Google Scholar 

  212. Hund G (1975) Vitamin-A-Saure-Therapie von Mollusca contagiosa bei Haemophilie. A Z Hautkrankht 50: 291–292

    CAS  Google Scholar 

  213. Humi MA, Bohlen L, Furrer H, Braathen LR (1997) Complete regression of giant molluscum contagiosum lesions in an HIV-infected patient following combined antiretroviral therapy with saquinavir, zidovudine and lamivudine. AIDS 11/14: 1784–1785

    Google Scholar 

  214. Ingraham HJ, Schoenleber DB (1998) Epibulbar molluscum contagiosum. Am J Ophthalmol 125/3: 394–396

    Article  Google Scholar 

  215. Liota E, Smith KJ, Buckley R, Menon P, Skelton H (2000) Imiquimod therapy for molluscum contagiosum. J Cutan Med Surg 4/2: 76–82

    Google Scholar 

  216. Pauly ChR, William MA, Henry EJ (1978) Atopic dermatitis impaired cellular immunity and molluscum contagiosum. Arch Dermatol114: 391–393

    Article  PubMed  CAS  Google Scholar 

  217. Romiti R, Ribeiro AP, Romiti N (2000) Evaluation of the effectiveness of 5 % potassium hydroxide for the treatment of mollusum contagiosum. Pedriatr Dermatol 17/6: 495

    Article  Google Scholar 

  218. Schwartz JJ, Myskowski PL (1992) Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol27/4: 583–588

    Article  Google Scholar 

  219. Simon M jr, Wieser E (1980) Ungewohnliche Molluscum contagiosum-Infektion bei Sarkoidose. Hautarzt 31: 341–343

    PubMed  Google Scholar 

  220. Whitaker SB, Wiegand SE, Budnick SD (1991) Intraoral molluscum contagiosum. Oral Surg Oral Med Oral Pathol 72/3: 334–336

    Article  Google Scholar 

  221. Berth-Jones, Hutchinson PE (1992) Modern treatment of warts: cure rates at 3 and 6 months. Br J Dermatol 127:262–265

    Article  PubMed  CAS  Google Scholar 

  222. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  223. Egawa K (1994) New types of human papillomaviruses and intracytoplasmatic inclusion bodies: a classification of inclusion warts according to clinical features, histology and associated HPV types. Br J Dermatol 130: 158–166

    Article  PubMed  CAS  Google Scholar 

  224. Gross G (1987) Lesions of the male and female external genitalia associated with human papillomaviruses. In: Syrjanen K, Gissmann L, Koss LG (eds) Papillomaviruses and human disease. Springer, Berlin Heidelberg New York Tokyo, pp 197-234

    Google Scholar 

  225. Gross G (1997) Therapy-skin warts. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 375

    Google Scholar 

  226. Gross G, Jablonska S (1997) Skin warts: morphology and histology. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 243

    Google Scholar 

  227. Gross G, Pfister H, Hagedorn M, Stahn R (1982) Effect of oral aromatic retinoid (Ro 10-9359) in human papilloma virus-2-induced common warts. Dermatol 78: 160–164

    CAS  Google Scholar 

  228. Grußendorf-Conen E-J (1990) Humanpathogene Papillomviren und deren Beziehungen zur Onkogenese. Hautarzt 41: 658–661

    PubMed  Google Scholar 

  229. Grußendorf-Conen E-J (1993) Humanpathogene Papillomviren in der Genese des Zervixkarzinoms. Fortschr Med 9: 145–146

    Google Scholar 

  230. Grußendorf-Conen E-J (1993) Behandlung von HPVinduzierten klinischen Veranderungen. Dtsch Arztebl 90: A 1 2326–2330

    Google Scholar 

  231. GruBendorf-Conen E-J (1993) HPV in der Onkogenese. Hautarzt 44: 427–431

    Google Scholar 

  232. Jablonska S, Majewski S, Obalek S, Orth G (1997) Cutaneous warts. Clin Dermatol15/3: 309–319

    Article  Google Scholar 

  233. Kimmig W, Kroger HJ, Hicks R, Breitbart W (1987) Ultraschallkontrollierte Nd-YAG-Lasertherapie von Viruspapillomen. Aktuel Dermatol13: 231–233

    Google Scholar 

  234. Lentner A, Wienert V (1996) Perianale Condylomata plana. Z Hautkrankht 8: 630–632

    Google Scholar 

  235. Moy R, Eliezri YD (1994) Significance of human papillomavirus-induced squamous cell carcinoma to dermatologists. Arch Dermatol 130: 235–237

    Article  PubMed  CAS  Google Scholar 

  236. Pfau A et al. (1994) Nd: YAG laser hyperthermia in the treatment of recalcitrant verrucae vulgares. (Regensburg's technique). Acta Derm Venereol 74: 212–214

    PubMed  CAS  Google Scholar 

  237. Robson KJ, Cunningham NM, Kruzan KL, Patel DS, Kreiter CD, O’Donnell MJ, Arpey CJ (2000) Pulsed-dye laser versus conventional therapy in the treatment of warts: a prospective randomized trial. J Am Acad Dermatol 43: 275–280

    Article  PubMed  CAS  Google Scholar 

  238. Schneider A, Wagner D (1993) Infektionen der Frau mit genitalem humanem Papillomvirus. Dtsch Arztebl 10: A 1 730–732

    Google Scholar 

  239. Stein E (1985) Warzen. Z Allgemeinmed 13: 3–5

    Google Scholar 

  240. Tyring SK (2000) Human papillomavirus infections: epidemiology, pathogenesis, and host immune response. JAm Acad Dermatol43: S18–26

    Article  CAS  Google Scholar 

  241. Villiers EM de (1992) Laboratory techniques in the investigation of human papillomavirus infection. Genitourin Med 68: 50–54

    PubMed  Google Scholar 

  242. Wimmershoff MB, Scherer K, Baumler W, Hohenleutner U, Landthaler M (2001) Behandlung von therapieresistenten Verrucae vulgares mit dem lang-gepulsten Farbstofflaser. Hautarzt 52: 701–704

    Article  PubMed  CAS  Google Scholar 

  243. Zur Hausen H (1977) Human papillomaviruses and their possible role in squamous cell carcinomas. Current Top Microbiol Immunol 78: 1–30

    Article  CAS  Google Scholar 

  244. Zur Hausen H (1982) Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet II: 1370–1372

    Google Scholar 

  245. Zur Hausen H (1987) Papillomaviruses in human cancer. Cancer 59: 1692–1696

    Article  PubMed  CAS  Google Scholar 

  246. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AMWF) (1999) Leitlinie zum Krankheitsbild der Feigwarzen in der anorektalen Region. Leitlinien der Deutschen Dermatologischen Gesellschaft. AWMF online, awmf@uni-duesseldorf.de

    Google Scholar 

  247. Beersiek E, Gross E, Eigler FW (1980) Die chirurgische Behandlung analer und intraanaler Condylomata acuminata. Coloproctology 6: 400–402

    Google Scholar 

  248. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  249. Brown TJ, Yen-Moore A, Tyring SK (1999) An overview of sexually transmitted diseases. Part II. J Am Acad Dermatol4115: 661–677

    Article  Google Scholar 

  250. Buschke A, Löwenstein L (1925) Über carcinomähnliehe Condylomata acuminata des Penis. Klin Woehensehr 4: 1726

    Article  Google Scholar 

  251. Edwards L, Ferenczy A, Eron L et al. (1998) Self-administered topical 5 % imiquimod cream for extern al anogenital warts. Arch Dermatol 134/1: 25–30

    Article  Google Scholar 

  252. Elsner P, Hartmann AA, Wecker J (1987) Condylomata acuminata-assoziierte STD-Infektionen der Urethra des Mannes. Eine vergleichende epidemiologische Studie. Hautarzt 38: 26–30

    PubMed  CAS  Google Scholar 

  253. Firlbeck G, Rassner G (1987) Behandlung von Condylomata acuminata mit systemisch applizierten rekombinanten Interferon gamma. Z Hautkrankht 62/17: 1280–1287

    Google Scholar 

  254. Gross G (1984) Condylomata acuminata und andere Papillomvirus-assoziierte Erkrankungen der Urogenital-und Analregion. Infekt Immun 12: 261–265

    CAS  Google Scholar 

  255. Gross G (1987) Lesions of the male and female external genitalia associated with human papillomaviruses. In: Syrjänen K, Gissmann L, Koss LG (eds) Papillomaviruses and human disease. Springer, Berlin Heidelberg New York Tokyo, pp 197–234

    Chapter  Google Scholar 

  256. Gross G (1988) HPV-Infektionen mit Essigsäure aufspüren. Sexualmedizin 17: 59–62

    Google Scholar 

  257. Gross G (2001) Condylomata acuminata und andere HPV-assoziierte Krankheitsbilder des Genitale und der Harnröhre. Leitlinie der Deutschen STD-Gesellschaft (DSTDG). Hautarzt 52: 405–410

    Article  PubMed  CAS  Google Scholar 

  258. Gross G (2001) HPV-Infektionen. In: Petzoldt D, Gross G (Hrsg) Diagnostik und Therapie sexuell übertragbarer Krankheiten-Leitlinien der Deutschen STD-GeseIlschaft. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  259. Gross G (2001) Klinik und Therapie anogenitaler Warzen und papillomvirusassoziierter Krankheitsbilder. Hautarzt 52: 6–17

    Article  PubMed  CAS  Google Scholar 

  260. Gross G, Pfister H, Hagedorn M, Gissmann L (1982) Correlation between human papillomavirus type (HPV) and histology of warts. J Invest Dermatol 78: 160–164

    Article  PubMed  CAS  Google Scholar 

  261. Gross G et al. (1985) Papillomavirus infection of the anogenital region: Correlation between histology, clinical picture and virus type. Proposal of a new nomenclature. J Invest Dermatol85: 147–152

    Article  PubMed  CAS  Google Scholar 

  262. Gross G, Roussaki A, Brzoska J (1988) Low doses of systemically administered recombinant interferongamma effective in the treatment of genital warts. J Invest Dermatol 90:242

    Google Scholar 

  263. Gross G, Roussaki A, Baur S, Wiegand M, Mescheder A (1996) Systematically administered interferon alfa-2aprevents recurrence of condylomata acuminata following C02-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial. Genitourin Med 72/1: 71

    Google Scholar 

  264. Gross G, Krogh G von, Barrasso R (1997) Therapy-genitoanallesions. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 389

    Google Scholar 

  265. Hengge UR, Benninghoff B, Ruzicka T, Goos M (2001) Topical immunomodulators-progress towards treating inflammation, infection, and cancer. Lancet Infect Dis 1: 189–198

    Article  PubMed  CAS  Google Scholar 

  266. Hohenleutner U et al. (1989) Condylomata acuminata gigantea (Buschke-Löwenstein-Tumor). Dtsch Med Wochenschr 113: 985–987

    Article  Google Scholar 

  267. Hohenleutner U, Landthaler M. Braun-Falco O (1990) Postoperative adjuvante Therapie mit Interferon-Alfa-2 b nach Laserchirurgie von Condylomata acuminata. Hautarzt 41/10: 545–548

    Google Scholar 

  268. Krogh G von (1976) 5-Fluorouracil cream in the successful treatment of therpeutical refractory condylomata acuminata of the urinary meatus. Acta Derm Venereol (Stockh) 56:297–301

    Google Scholar 

  269. Krogh G von, Gross G, Barrasso R (1997) Warts and HPV-related squamous cell tumors of the genitoanal area in adults. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 259

    Google Scholar 

  270. Krumm D (1987) Ergebnisse einer konservativen Therapie von Condylomata acuminata. Darstellung anhand eines Falles von analen Condylomen. Dt Derm 35/3: 269–275

    Google Scholar 

  271. Landthaler M (1994) Anogenitale Feigwarzen: Behandlung heute aussichtsreicher. Med Trib 29:8

    Google Scholar 

  272. Luchtefeld MA (1994) Perianal condylomata acuminatao Surg Clin North Am 74/6: 1327–1338

    Google Scholar 

  273. Prasad J, Isbister WH (1995) Perianale Condylomata acuminata. Coloproctology 3: 111–113

    Google Scholar 

  274. Rock B, Shabh KV, Farmer ER (1992) A morphologic, pathologic, and virologic study of anogenital warts in men. Arch Dermatol 128/4: 495–500

    Article  Google Scholar 

  275. Simmons PD (1981) Podophyllin 10% and 25% in the treatment of ano-genital warts. A comparative doubleblind study. Br J Vener Dis 57: 208–209

    PubMed  CAS  Google Scholar 

  276. Stein E (1983) Therapiemethoden bei Vorliegen von Condylomata acuminata. Med Trib 6: 37–38

    Google Scholar 

  277. Stein E (1984) Condylomata acuminata. Der informierte Arzt 7: 6–10

    Google Scholar 

  278. Thomson JPS et al. (1978) The treatment of perianal and anal condylomata acuminata: a new operative technique. J R Soc Med 71: 180–185

    PubMed  CAS  Google Scholar 

  279. Wagner G, Kowalzick L (1992) Erfolgreiche systemische Behandlung vorher therapieresistenter Condylomata acuminata mit rekombinantem Gamma-Interferon. Aktuel Dermatol18: 180–182

    Google Scholar 

  280. Weismann K, Kassis V (1982) Behandlung von Condylomata acuminata mit 0,5 %iger 5-Fluorouracil-Lösung. Eine doppelblindklinische Untersuchung. Z Hautkrankht 57: 810–816

    CAS  Google Scholar 

  281. Wienert V (1999) Krankheitsbild der Feigwarzen in der anorektalen Region. Coloproctology 21: 38–41

    Article  Google Scholar 

  282. Wienert V (2001) Feigwarzen in der anorektalen Region. In: Korting HC, Callies R, Reusch M, Schlaeger M, Schöpf E, Sterry W (Hrsg) Dermatologische Qualitätssicherung-Leitlinien und Empfehlungen, 2. Aufl. Zuckschwerdt, München, S 128–133

    Google Scholar 

  283. Zur Hausen H (1989) Papilloma virus es in anogenital cancer as a model to understand the role of virus es in human cancers. Cancer Res 49: 4677–4681

    PubMed  CAS  Google Scholar 

  284. Braun-Fako O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  285. Civatte J (1983) Die falschen Formen von Morbus Bowen an den Genitalschleimhäuten. Hautarzt 34: 298–305

    PubMed  CAS  Google Scholar 

  286. Fierlbeck G (1993) Topische Interferon-Therapie: Kritische Bewertung. In: Braun-Falco O, Plewig G, Meurer M (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie, Bd. 13. Springer, Berlin Heidelberg New York Tokyo, S 407–412

    Chapter  Google Scholar 

  287. Friedrich EG (1972) Reversible vulvar atypia. A case report. Obstet Gynecol 39: 173–181

    PubMed  Google Scholar 

  288. Gross G (1987) Lesions of the male and female extern al genitalia associated with human papillomaviruses. In: Syrjänen K, Gissmann L, Koss LG (eds) Papillomaviruses and human disease. Springer, Berlin Heidelberg New York Tokyo, pp 197–234

    Google Scholar 

  289. Gross G, Barrasso R (1997) Human papillomavirus infection. A clinical atlas. Ullstein/Mosby, München Chicago

    Google Scholar 

  290. Gross G et al. (1985) Papillomavirus infection of the anogential region: Correlation between histology, clinical picture and virus type. Proposal of a new nomenclature. J luvest Dermatol85: 147–152

    Article  CAS  Google Scholar 

  291. Gross G et al. (1985) Bowenoid Papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences in bowenoid papulosis. Arch Dermatol121: 858–863

    Article  PubMed  CAS  Google Scholar 

  292. Gross G, Wagner D, Hauser-Brauner B, Ikenberg H, Gissmann L (1985) Bowenoide Papulose und Carcinoma in situ der Cervix uteri bei Sexualpartnern. Ein Beispiel für die Übertragbarkeit der HPV-16-lnfektion. Hautarzt 36/8:465–469

    Google Scholar 

  293. Gross G, Krogh G von, Barrasso R (1997) Therapy-genitoanallesions. In: Groß G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 389

    Google Scholar 

  294. Grussendorf-Conen EJ (1988) HPV-16-induzierte pigmentierte bowenoide Papulose am Hals. Aktuel Dermatol14: 317–319

    Google Scholar 

  295. Hagedorn M, Faber M (1979) Multizentrisches bowenoides Akanthom-ein neues Krankheitsbild im genito-analen Bereich. Aktuel Dermatol 5: 185–190

    Google Scholar 

  296. Hauser B, Gross G, Schneider A, Villiers EM de, Gissmann L, Wagner D (1985) HPV-16-related Bowenoid papulosis. Lancet 2/8446: 106

    Article  Google Scholar 

  297. Höpfl R, Guger M, Widschwendter A (2001) Humane Papillomviren und ihre Rolle bei der Karzinogenese. Hautarzt 52: 834–846

    Article  PubMed  Google Scholar 

  298. Ikenberg H, Gissmann L, Gross G, Grussendorf-Conen EI, zur Hausen H (1983) Human papillomavirus type 16 related DNA in genital Bowen's disease and in Bowenoid Papulosis. Int J Cancer 32: 563–565

    Article  PubMed  CAS  Google Scholar 

  299. Kopf AW, Bart RS (1977) Tumor conference No 11. Multiple bowenoid papules of the penis: a new entity? J Dermatol Surg Oncol 3: 265–269

    PubMed  CAS  Google Scholar 

  300. Lloyd KM (1970) Multicentric pigmented Bowen's disease of the groin. Arch Dermatol101: 48–51

    Google Scholar 

  301. Majewski S, Jablonska S (1997) Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 36/5: 659 ff.

    Article  Google Scholar 

  302. Materna U, Zabel M, Hettwer H (1996) Frühinvasives Plattenepithelkarzinom bei bowenoider Papulose (VIN III) Triggerung durch virale (HPV 16-) und bakterielle (Chlamydien-) Infektionen? Z Hautkrankht 1: 15–20

    Google Scholar 

  303. Palefsky J (1997) HPV related disease in immunosuppressed individuals. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 227

    Google Scholar 

  304. Schwartz RA, Janninger CK (1991) Bowenoid papulosis. J Am Acad Dermatol 24: 261–264

    Article  PubMed  CAS  Google Scholar 

  305. Wade TR, Kopf AW, Ackerman AB (1979) Bowenoid papulosis of the Genitalia. Arch Dermatol115:306–308

    Article  PubMed  CAS  Google Scholar 

  306. Wigbels B, Luger T, Metze D (2001) Imiquimod-eine neue Therapiemöglichkeit der bowenoiden Papulose? Hautarzt 52/2: 128–131

    Article  Google Scholar 

  307. Zachow KR, Ostrow RS, Bender M et al. (1982) Detection of human papillomavirus DNA in anogenital neoplasias. Nature 300: 771–773

    Article  PubMed  CAS  Google Scholar 

  308. Andersen SLC, Nielsen A, Reymann F (1973) Relationship between Bowen disease and internal malignant tumors. Arch Dermatol 108: 367

    Article  PubMed  CAS  Google Scholar 

  309. Beck SC (1933) Epitheliome. In: Jadassohn J (Hrsg) Handbuch der Haut-und Geschlechtskrankheiten. Bd XII/3. Springer, Berlin, S433

    Google Scholar 

  310. Berger BW, Hori Y (1978) Multicentric Bowen's disease of the genitalia. Arch Dermatol 114: 1698

    Article  PubMed  CAS  Google Scholar 

  311. Bowen JT (1912) Precancerous dermatoses: A study of 2 cases of chronic atypical epithelial proliferation. J Cutan Dis 30: 241

    Google Scholar 

  312. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  313. Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM (2000) Treatment options for perianal Bowen's disease: survey of American Society of Colon and Rectal Surgeons Members. Am Surg 6617:686–688

    Google Scholar 

  314. Gebbers J-O, Laissue J-A (1984) Pathologie der Analtumoren. Schweiz Rundschau Med (Praxis) 27: 847–862

    Google Scholar 

  315. Graham JH, Helwig EB (1959) Bowen's disease and its relationship to systemic cancer. Arch Dermatol 80: 133

    Article  CAS  Google Scholar 

  316. Gross G (1987) Lesions of the male and female external genitalia associated with human papillomaviruses. In: Syrjänen K, Gissmann L, Koss LG (eds) Papillomaviruses and human disease. Springer, Berlin Heidelberg New York Tokyo, p 197

    Chapter  Google Scholar 

  317. Gross G, Krogh G von, Barrasso R (1997) Therapy-genitoanallesions. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 389

    Google Scholar 

  318. Höpfl R, Guger M, Widschwendtner A (2001) Humane Papillomviren und ihre Rolle bei der Karzinogenese. Hautarzt 52: 834–846

    Article  PubMed  Google Scholar 

  319. Ikenberg H, Gissmann L, Gross G, Grussendorf-Conen EJ, zur Hausen H (1983) Human papillomavirus type-16-related DNA in genital Bowen's disease and in bowenoid papulosis. Int J Cancer 32: 563–565

    Article  PubMed  CAS  Google Scholar 

  320. Jaeger AB, Gramkow A, Hjalgrim H, Melbye M, Frisch M (1999) Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients. Arch Dermatol135/7: 790–793

    Article  Google Scholar 

  321. Krogh G von, Gross G, Barrasso R (1997) Warts and HPV-related squamous cell tumors of the genitoanal area in adults. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 259

    Google Scholar 

  322. Majewski S, Jablonska S (1997) Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 36/5: 659–685. 659-685

    Article  Google Scholar 

  323. Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC (1997) Perianal Bowen's disease: a clinicopathologic study of 47 patients. Dis Colon Rectum 40/11: 1286–1293

    Google Scholar 

  324. Nordin P, Stenquist B, Hansson BG (1994) Joint occurence of human papillomavirus type 16 DNA in Bowen's disease on a finger and in dysplasia of the vulva and the uterine cervix. Br J Dermatol131/5: 740

    Article  Google Scholar 

  325. Runfola MA, Weber TK, Rodriguez-Bigas MA, Dougherty TJ, Petrelli NJ (2000) Photodynamic therapy for residual neoplasms of the perianal skin. Dis Colon Rectum 43/4: 499–502

    Article  Google Scholar 

  326. Sarmiento JM, Wolff BG, Burgart LJ, Frizelle FA, Il-strup DM (1997) Perianal Bowen's disease: associated tumors, human papillomavirus, surgery, and other controversies. Dis Colon Rectum 40/8: 912–918

    Article  Google Scholar 

  327. Schmidt K-U, Wiskemann A, Mensing H (1986) Etretinat und 5-Fluorouracil bei intraanalem M. Bowen. Der Hautarzt 37:278–280

    CAS  Google Scholar 

  328. Thestrup-Pedersen K et al. (1988) Morbus Bowen. A description of the disease in 617 patients. Acta Dermatol Venerol (Stockh) 68: 236–239

    CAS  Google Scholar 

  329. Buschke A, Löwenstein L (1925) Über carcinomähnliche Condylomata acuminata des Penis. Klin Wochenschr 4: 1726

    Article  Google Scholar 

  330. Buschke A, Löwenstein L (1932) Über die Beziehungen von spitzen Kondylomen zu Karzinomen des Penis. Dtsch Med Wochenschr 58:809

    Article  Google Scholar 

  331. Chu QD, Vezeridis MP, Libbey NP, Wanebo HJ (1994) Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum 37/9: 950–957

    Article  Google Scholar 

  332. Cosman BC, O'Grady TC, Pekarske S (2000) Verrucous carcinoma arising in hidrademitis suppurativa. Int J Colorectal Dis 15:342–346

    Article  PubMed  CAS  Google Scholar 

  333. Cuesta KH, Palazzo JP, Mittal KR (1998) Detection of human papillomavirus in verrucous carcinoma from HIV-seropositive patients. J Cutan Pathol 25/3: 165–170

    Article  Google Scholar 

  334. Hohenleutner U et al. (1989) Condylomata acuminata gigantea (Buschke-Löwenstein-Tumor). Dtsch Med Wochenschr 113: 985–987

    Article  Google Scholar 

  335. Höpfl R, Guger M, Widschwendtner A (2001) Human Papillomviren und ihre Rolle bei der Karzinogenese. Hautarzt 52: 834–846

    Article  PubMed  Google Scholar 

  336. Löwenstein L (1939) Carcinoma-like Condylomata acuminata of the penis. Surg Clin N Am 23: 789

    Google Scholar 

  337. Majewski S, Jablonska S (1997) Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 3615: 659–685

    Article  Google Scholar 

  338. Noel JC, Sornin De Leysat C, Peny MO, De Stadt J van, Fayt I, De Dobbeleer G (2001) Warty carcinoma of the anus: a variant of a squamous cell carcinoma associated with anal intraepithelial neoplasia and human papillomavirus infection. Dermatology 203/3: 262–264

    Google Scholar 

  339. Richter M et al. (1995) Plattenepithelkarzinom in einem perianalen Buschke-Löwenstein-Tumor. Coloproctology 5: 236–239

    Google Scholar 

  340. Sobrado CW, Mester M, Nadalin W, Nahas SC, Bocchini SF, Habr-Gama A (2000) Radiation-induced total regression of a highly recurrent giant perianal condyloma. Report of a case. Dis Colon Rectum 43: 257–260

    Article  PubMed  CAS  Google Scholar 

  341. Vandeweyer E, Sales F, Deraemaecker R (2001) Cutaneous verrucous carcinoma. Br J Plast Surg 54/2: 168–170

    Article  Google Scholar 

  342. Agathos M (1994) Skabies. Hautarzt 45: 889–903

    Article  PubMed  CAS  Google Scholar 

  343. Brown S, Becher J, Brady W (1995) Treatment of ectoparasitic infections: review of the English-language literature. Clin Infect Dis 20 (Suppl 1): S104–109

    Article  Google Scholar 

  344. Burkhart CG, Burkhart CN, Burkhart KM (2000) An epidemiologic and therapeutic reassessment of scabies. Cutis 65/4: 233–240

    Google Scholar 

  345. Bums DA (1991) The treatment of human ectoparasite infection. Br J Dermatol 125: 89–93

    Google Scholar 

  346. Estes SA (1993) Therapy of scabies: nursing hornes, hospitals, and the homeless. Semin Dermatol12: 26–33

    PubMed  CAS  Google Scholar 

  347. Föster-Holst R, Rufli T, Christophers E (2000) Die Skabiestherapie unter besonderer Berücksichtigung des frühen Kindesalters, der Schwangerschaft und Stillzeit. Hautarzt 51: 7–13

    Article  Google Scholar 

  348. Haas N (1987) Eine einfache vitalmikroskopische Hilfe zum Nachweis von Skabiesmilben. Z Hautkrankht 62: 1395–1398

    CAS  Google Scholar 

  349. Haustein U-F (1991) Pyrethrine und Pyrethroide (Permethrin) bei der Behandlung von Skabies und Pediculosis. Hautarzt 42: 9–15

    PubMed  CAS  Google Scholar 

  350. Haustein U-F, Franz H (2001) Antiparasitika. In: Korting HC, Sterry W (Hrsg) Therapeutische Verfahren in der Dermatologie: Dermatika und Kosmetika. Blackwell, Berlin, S.337–345

    Google Scholar 

  351. Jung EG (1980) Scabies. Aktuel Dermatol 6: 77–84

    Google Scholar 

  352. Madan V, Jaskiran K, Gupta U, Gupta DK (2001) Oral ivermectin in scabies patients: a comparison with 1 % topicallindane lotion. J Dermato128/9: 481–484

    Google Scholar 

  353. Meinking TL, Elgart GW (2000) Scabies therapy for the millenium. Pediatr Dermatol17/2: 154–156

    Article  Google Scholar 

  354. Mellanby K (1953) Scabies. Oxford University Press, London, pp 1–81

    Google Scholar 

  355. Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  356. Orkin M, Maibach HI (1993) Scabies therapy-1993. Semin Dermatol 12:22–25

    PubMed  CAS  Google Scholar 

  357. Paasch U, Haustein U-F (2001) Behandlung der endemischen Skabies mit Allethrin, Permethrin und Ivermectin. Evaluation eines Behandlungskonzeptes. Hautarzt 52: 31–37

    Article  PubMed  CAS  Google Scholar 

  358. Purvis RS, Tyring SK (1991) An outbreak of lindaneresistant scabies treated successfully with permethrin 5% cream. J Am Acad Dermato125: 1015–1016

    Article  Google Scholar 

  359. Roos TC, Alam M, Roos S, Merk HF, Bickers DR (2001) Pharmacotherapy of ectoparasitic infections. Drugs 61/8: 1067–1088

    Article  Google Scholar 

  360. Roth WI (1991) Scabies resistant to lindane 1 % lotion and crotamiton 10% cream. J Am Acad Dermatol 24: 502–503

    Article  PubMed  CAS  Google Scholar 

  361. Schirren JM (1970) Die Scabies, eine epidemiologische Studie. Hautarzt 21: 170–176

    PubMed  CAS  Google Scholar 

  362. Stein E (1974) Uncharakteristische dermatologische Krankheitsbilder durch Kortikosteroid-KombiantionsExterna. Ärztl Praxis 14: 613

    Google Scholar 

  363. Stüttgen G (1992) Skabies und Läuse heute. Dtsch Ärztebl17: AI–1534–AI–1546

    Google Scholar 

  364. Walker GJ, Johnstone PW (2000) Interventions for treating scabies. Cochrane Database Syst Rev 3: CD000320

    Google Scholar 

  365. Braun-Fako O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  366. Brown S, Becher I, Brady W (1995) Treatment of ectoparasitic infections: review of the English-Ianguage literature, 1982-1992. Clin Infect Dis 20 (Suppll): S104–109

    Article  Google Scholar 

  367. Brown TI, Yen-Moore A, Tyring SK (1999) An overview of sexually transmiited diseases. Part II. J Am Acad Dermatol41/5: 661–677

    Article  Google Scholar 

  368. Bums A (1987) The treatment ofPhthirus pubis infestation of the eyelashes. Br I Dermatol117: 741–743

    Article  Google Scholar 

  369. Kalter DC et al. (1987) Treatment of pediculosis pubis. Arch Dermatol 123: 1315–1319

    Article  PubMed  CAS  Google Scholar 

  370. Opaneye AA, Iayaweera DT, Walzmann M, Wade AA (1993) Pediculosis pubis: a surrogate marker for sexualIy transmitted diseases. I R Soc Health 113/1: 6–7

    Article  Google Scholar 

  371. Scott GR (2001) European guideline for the management of pediculosis pubis. Int I STD AIDS (Suppl) 3/10: 62

    Article  Google Scholar 

  372. Berbis P (2001) Acitretine. Ann Dermatol Venereol 128/6-7: 737–745

    Google Scholar 

  373. Bobadilla J, Hulst RW van der, Kate FL ten, Tytgat GN (1999) Esophageal lichen planus. Gastrointest Endosc 50/2: 268–271

    Article  Google Scholar 

  374. Cribier B, Frances C, Chosidow O (1998) Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol134/12: 1521–1530

    Article  Google Scholar 

  375. Epstein JB, Truelove EL (1996) Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82/5: 532–536

    Google Scholar 

  376. Fundaro S, Spallanzani A, Ricchi E et al. (1998) Squamous-cell carcinoma developing within anal lichen planus: report of a case. Dis Colon Rectum 4111: 111–114

    Article  Google Scholar 

  377. Helm T et al. (1994) Lichen planus associated with neoplasia. A cell-mediated immune response to tumor antigens? J Am Acad Dermatol 30: 219–224

    Article  PubMed  CAS  Google Scholar 

  378. Lener EV, Brieva J, Schachter M, West LE, West DP, elAzhary RA (2001) Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol137/4: 419–422

    Google Scholar 

  379. Maercke P van et al. (1988) Lichen ruber mucosae with esophageal involvement. Endoscopy 20: 158–160

    Article  PubMed  Google Scholar 

  380. Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  381. Payne CM, McPartiin JF, Hawley PR (1997) Ulcerative perianallichen planus. Br J Dermatol 136/3: 479

    Article  Google Scholar 

  382. Rußwurm R, Hagedorn M (1989) Lichen ruber ulcerosus. Hautarzt 40: 233–235

    PubMed  Google Scholar 

  383. Shai A, Halevy S (1992) Lichen planus und Lichen planus-like eruptions. Pathogenesis and associated diseases. Int J Dermatol 31: 379–384

    Article  PubMed  CAS  Google Scholar 

  384. Wörheide J et al. (1991) Plattenepithelkarzinom auf dem Boden eines Lichen ruber hypertrophicus an der Glans penis. Hautarzt 42: 112–115

    PubMed  Google Scholar 

  385. Woo TY (1985) Systemic isotretinoin treatment of oral and cutaneous lichen planus. Cutis 35: 385–393

    PubMed  CAS  Google Scholar 

  386. Barker LP, Gross P (1962) Lichen sclerosus et atrophicus of the female genitalia. A clinical study and diagnostic guide. Arch Dermatol 85: 362–373

    Article  PubMed  CAS  Google Scholar 

  387. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin HeidelbergNew York Tokyo

    Book  Google Scholar 

  388. Cruces MJ, De la Torre C, Losada A, Ocampo C, Garcia-Doval I (1998) Infantile pyramidal protrusion as a manifestation of lichen sclerosus et atrophicus. Arch Dermatol 134/9: 1118–1120

    Article  Google Scholar 

  389. Darier J (1892) Lichen plan sclereux. Ann Dermatol Syph 23: 833–837

    Google Scholar 

  390. Garzon MC, Paller AS (1999) Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus. Arch Dermatol 135/5: 525–528

    Article  Google Scholar 

  391. Greve B, Hartschuh W, Raulin C (1999) Extragenitaler Lichen sclerosus et atrophicus-Behandlung durch gepulsten Farbstofflaser. Hautarzt 50: 805–808

    Article  PubMed  CAS  Google Scholar 

  392. Hadlich J, Linse R (1983) Zur klinisch-histologischen Variationsbreite des Lichen sclerosus et atrophicus. Hautarzt 34: 453–455

    PubMed  CAS  Google Scholar 

  393. Hagedorn M (1987) Lichen sclerosus et atrophicus: Behandlung mit Thym-Uvocal Creme. Aktuel Dermatol 13: 30–33

    Google Scholar 

  394. Hallopeau H (1887) Lelfons cliniques sur les maladees cutanées et syphiliques. Union Med Can 43: 472

    Google Scholar 

  395. Hofmann U, Megahed M (1994) Spinozelluläres Karzinom auf einem Lichen sclerosus et atrophicus der Vulva. Hautarzt 45: 104–107

    Article  PubMed  CAS  Google Scholar 

  396. Kerscher M (1994) Treatment of localized scleroderma with PUVA-bath photochemotherapy. Lancet 343: 1233

    Article  PubMed  CAS  Google Scholar 

  397. Kobyletzki G von, Freitag M, Hoffmann K, Altmeyer P, Kerscher M (1997) Balneophotochemotherapie mit 8-Methoxypsoralen bei Lichen sclerosus et atrophicus. Hautarzt 48/7: 488–491

    Article  Google Scholar 

  398. Kreuter A, Jansen T, Stucker M, Herde M, Hoffmann K, Altmeyer P, Kobyletzki G (2001) Low-dose ultravioletAl phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 26/1: 30–32

    Article  Google Scholar 

  399. Lipscombe TK, Wayte J, Wojnarowska F, Marren P, Luzzi G (1997) A study of clinical and aetiological factors and possible associations of lichen sclerosus in males. Australas J Dermatol 38/3: 132–136

    Article  Google Scholar 

  400. Meffert H, Davis BM, Grimwood RE (1995) Lichen sclerosus. J Am Acad Dermatol 32/3: 393–416

    Article  Google Scholar 

  401. Pampor M (1996) Therapie des Lichen sclerosus et atrophicus. Hautarzt 6: 429–430

    Google Scholar 

  402. Röcken M et al. (1995) Balneophototherapie. Hautarzt 46: 437–450

    Article  PubMed  Google Scholar 

  403. Silverio A, Serri S (1975) Generalized bullous and haemorrhagic lichen sclerosus et atrophicus. Br J Dermatol 93: 215–217

    Article  PubMed  Google Scholar 

  404. Skierlo P, Heise H (1987) Testosteronpropionat-Salbe-ein Therapieversuch beim Lichen sclerosus et atrophicus. Hautarzt 38: 295–297

    PubMed  CAS  Google Scholar 

  405. Tritsch H (1968) Adenoides Plattenepithelcarcinom bei Lichen sclerosus et atrophicus. Arch Klin Exp Dermatol 232: 187–194

    PubMed  CAS  Google Scholar 

  406. Warrington SA, San Lazaro C de (1996) Lichen sclerosus et atrophicus and sexual abuse. Arch Dis Child 75/6: 512–516

    Article  Google Scholar 

  407. Wier RF (1875) Ichtyosis of the tongue and vulva. NY State Y Med 246

    Google Scholar 

  408. Assmann K, Bonsmann G, Werner C, Metze D (2001) Acrodermatitis-enteropathica-ähnliche Hautveränderungen bei Ahornsirupkrankheit. Z Hautkr 76: 220–222

    Google Scholar 

  409. Brandt T (1936) Dermatitis in children with disturbances of the general condition and the absorption of food elements. Acta Derm Venerol (Stockh) 17: 513–546

    Google Scholar 

  410. Bryant TN (1981) Comparison of procedures for determination of cop per and zinc in serum by atomic absorptions spectroscopy. Clin Chim Acta 110: 83–90

    Article  PubMed  Google Scholar 

  411. Danbolt N, Closs K (1942) Akrodermatitis enteropathica. Acta Derm Venerol (Stockh) 23: 127–169

    Google Scholar 

  412. Dupré A, Bonate JL, Carriere JP (1979) The hair in acrodermatitis enteropathica: A disease indicator? Acta Derm Venerol (Stockh) 59: 177–l78

    PubMed  Google Scholar 

  413. Ferrandiz C et al.(1981) Acquired zinc deficiency syndrome during total parenteral alimentation. Dermatologica 163: 255–266

    Article  PubMed  CAS  Google Scholar 

  414. Gschnait Th et al.(1982) Das exogen bedingte Zinkmangelsyndrom. Wien Klin Wochenschr 94: 475–479

    PubMed  CAS  Google Scholar 

  415. Kaufmann J (1984) Acrodermatitis enteropathica bei totaler parenteraler Ernährung wegen Morbus Crohn. Z Hautkrankht 59: 1447–1453

    CAS  Google Scholar 

  416. Kay RG, Tasman-Jones C, Pydus J, Whiting R, Black H (1976) A syndrome of acute zinc deficiency during total parenteral alimentation in man. Ann Surg 183: 331–340

    Article  PubMed  CAS  Google Scholar 

  417. Krasovec M, Frenk E (1996) Acrodermatitis enteropathica secondary to Crohn's disease. Dermatology 193/4: 361–363

    Article  Google Scholar 

  418. Löffler H, Effendy I (1999) Acrodermatitis-enteropathica-ähnliche Hautveränderungen durch parenterale Ernährung. Hautarzt 50: 499–502

    Article  PubMed  Google Scholar 

  419. Moynahan EI, Barnes PM (1973) Zinc deficiency and a synthetic diet for lactose intolerance. Lancet 1: 676

    Article  PubMed  CAS  Google Scholar 

  420. Moynahan EJ (1974) Acrodermatitis enteropathica. A lethal inherited human zincdeficiency disorder. Lancet II: 399

    Article  Google Scholar 

  421. Nürnberger F (1987) Zinkmangel bei künstlicher Ernährung. Z Hautkrankht 62: 104–110

    Google Scholar 

  422. Okada A, Takagi Y, Itakura T et al. (1976) Skin lesions during intravenous hyperalimentation: Zinc deficiency. Surgery 80: 629–635

    PubMed  CAS  Google Scholar 

  423. Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York Tokyo, S 704–705

    Book  Google Scholar 

  424. Panizzon R (1995) Hautsymptome bei Störungen des Vitamin-und Mineralhaushalts. Ther Umsch 52/4: 257–263

    Google Scholar 

  425. Reich H, Opitz K, Bertram H-P, Fegeler K (1976) Lebensrettende Zinkbehandlung der Acrodermatitis enteropathica. Dtsch Med Wochenschr 101: 1724–1726

    Article  PubMed  CAS  Google Scholar 

  426. Schwarz T, Rütter A (1996) Zink in der Dermatologie. TW Dermatologie 26: 372–377

    Google Scholar 

  427. Stein E (1982) Das Crohn-Syndrom. Z Allgemeinmed 31: 1702–1715

    Google Scholar 

  428. Vloten WA van, Bos LP (1978) Skin lesions in acquired zinc deficiency due to parenteral nutrition. Dermatologica 156: 175–183

    Article  PubMed  Google Scholar 

  429. Wang K, Pugh EW, Griffen S et al. (2001) Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3. Am J Hum Genet 68/4: 1055–1060

    Article  Google Scholar 

  430. Weismann K, Hoyer H, Christensen E (1980) Acquired zinc deficiency in alcoholic liver cirrhosis: Report of two cases. Acta Derm Venerol (Stockh) 60: 447–449

    PubMed  CAS  Google Scholar 

  431. Weismann K, Hoyer H (1982) Zinkmangeldermatosen. Der Hautarzt 33: 405–410

    CAS  Google Scholar 

  432. Alkemade JA, Tongeren JH van, Haelst UJ van, Smals A, Steijlen PM, Kerkhoff PC van de (1999) Delayed diagnosis of glueagonoma syndrome. Clin Exp Dermatol 24/6: 455–457

    Article  Google Scholar 

  433. Beeker SW et al. (1942) Cutaneous manifestations of internal malignant tumours. Areh Dermatol Syphilol 45: 1069–1080

    Article  Google Scholar 

  434. Chastain MA (2001) The glueagonoma syndrome: a review of its features and diseussion of new perspeetives. Am J Med Sei 321/5: 306–320

    Google Scholar 

  435. Darouty M el, Abu el Ela M (1996) Neerolytic migratory erythema without glueagonoma in patients with liver disease. J Am Aead Dermatol 34/6: 1092–1093

    Article  Google Scholar 

  436. Delaporte E, Catteau B, Piette F (1997) Neerolytic migratory erythema-like eruption in zine defieieney assoeiated with alcoholie liver disease. Br J Dermatol137/6: 1027–1028

    Google Scholar 

  437. Engelmann L et al. (1991) Erythema necrolyticum migrans-Glukogonom-Syndrom Aktuel Dermatol17:11–17

    Google Scholar 

  438. Kasper CS (1992) Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A ease report and literature review. Cutis 49/2: 120–122, 125-128

    Google Scholar 

  439. Konstantinow A, Balda BR, Starz H (1998) Erythema neerolyticum migrans nach Rektumkarzinom. Hautarzt 49/7: 591–595

    Article  Google Scholar 

  440. Mc Gavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME (1966) A glueagon-secreting alpha-cell eareinomaof the pancreas. N Engl J Med 274/25: 1408–1413

    Article  Google Scholar 

  441. Meyer J, Seidel B (1998) Dapson-Therapie des Erythema necroticans migrans bei „Pseudoglukagonom-Syndrom“ Akt Dermatol 24: 275–277

    Google Scholar 

  442. Nightingale KJ, Davies MG, Kingsnorth AN (1999) Glucagonoma syndrome: survival 24 years following diagnosis. Dig Surg 1611: 68–7 ai]12_Ossowski B, Baum C (1995) Das PseudoglukagonomSyndrom. Fallbericht, therapeutische Möglichkeiten und Hypothesen zur Ätiologie. Hautarzt 46/3: 173–176

    Article  Google Scholar 

  443. Pfau A et al. (1995) Das Glukogonom-Syndrom-Klinik und Therapie. Z Hautkrht 10: 725–728

    Google Scholar 

  444. Rappersberger K, Wolff-Schreiner E, Konrad K, Wolff K (1987) Das Glukogonom-Syndrom. Hautarzt 38: 589–598

    PubMed  CAS  Google Scholar 

  445. Sinclair SA, Reynolds NJ (1997) Neerolytic migratory erythema and zinc defieiency. Br J Dermatol 136/5: 783–785

    Article  Google Scholar 

  446. Soga J, Yakuwa Y (1998) Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases. J Hepatobiliary Pancreat Surg 5/3. 312–319

    Article  Google Scholar 

  447. Strohm WD (1996) Paraneoplastische spastische Tetraparese bei Glukogonom-Syndrom. Erfolgreiche Therapie mit Octreotid, Dacarbacin und Interferon-a. Z Gastroenterol 34: 438–445

    PubMed  CAS  Google Scholar 

  448. Sweet RD (1974) A dermatosis specifically associated with a tumor of pancreatic alpha cells. Br J Dermatol 90/3: 301–308

    Article  Google Scholar 

  449. Thorisdottir K, Camisa C, Tomecki KJ, Bergfeld WF (1994) Necrolytic migratory erythema: areport of three cases. J Am Acad Dermatol 30: 324–329

    Article  PubMed  CAS  Google Scholar 

  450. Wermers RA, Fatourechi V, Kvols LK (1996) Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors. Mayo Clin Proc 71/11: 1030–1038

    Article  Google Scholar 

  451. Wilkinson DS (1971) Necrolytic migratory erythema with pancreatic carcinoma. Proc R Soc Med 64: 1197–1198

    PubMed  CAS  Google Scholar 

  452. Andreev VC, Boyanov L, Tsankov N (1981) Generalized acanthosis nigricans. Dermatologica 163: 19–24

    Article  PubMed  CAS  Google Scholar 

  453. Böhm M, Luger A, Metze D (1999) Urthelkarzinom-assoziierte Acanthosis nigricans-symptomatische Therapie mit Cakipotriol. Hautarzt 50: 593–596

    Article  PubMed  Google Scholar 

  454. Bonnekoh B, Thiele B, Merk H, Mahrle G (1989) Systemische Photo chemotherapie (PUVA) bei Acanthosis nigricans maligna: Regression von Keratose, Hyperpigmentierung und Pruritus. Z Hautkrankht 64: 1059–1062

    CAS  Google Scholar 

  455. Braun-Fako O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  456. Curth-Ollendorff H (1979) Malignant Acanthosis nigricans. In: Fitzpatrick TB et al. (ed) Dermatology in general medicine,2 nd edn. McGraw-Hill, New York, 1346 ff

    Google Scholar 

  457. Darmstadt GL, Yokel BK, Horn TD (1991) Treatment of acanthosis nigricans with tretinoin. Arch Dermatol 127: 1139–1140

    Article  PubMed  CAS  Google Scholar 

  458. EImer KB, George RM (2001) HAIR-AN syndrome: a multisystem challenge. Am Farn Physician 63/12: 2385–2390

    Google Scholar 

  459. Janovsky V (1890) Acanthosis nigricans. Internat. Atlas seltener Hautkrankheiten, Bd 11

    Google Scholar 

  460. Larregue M et al.(1979) Pachydermatoglyphie. Signe en faveur de la malignite au cours de l'acanthosis nigricans. Ann Dermatol Venereol (Paris) 106:781–785

    PubMed  CAS  Google Scholar 

  461. Marghescu S, Wolff H, Braun-Fako O (1982) Kongenitale Erythrokeratodermie mit Taubheit Schnyder. Hautarzt 33: 416–419

    PubMed  CAS  Google Scholar 

  462. Matsuoka LY, Wortsman J, Goldman J (1993) Acanthosis nigricans. Clin Dermatol 11: 21–25

    Article  PubMed  CAS  Google Scholar 

  463. Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  464. Pollitzer S (1890) Acanthosis nigricans. Internat. Atlas seltener Hautkrankheiten, Bd 10

    Google Scholar 

  465. Requena L, Aguilar A, Renedo G, Martin L, Pique E, Farina MC, Escalonilla P (1995) Tripe palms: a cutaneous marker of internal malignancy. J Dermatol 22/7:492–495

    Google Scholar 

  466. Schönlein K-M, Worret W-J (1994) Paraneoplastische Syndrome der Haut. hautnah 3: 301–310

    Google Scholar 

  467. Schnyder UW (1971) Vorwort. In: Herzberg JJ (Hrsg) Kutane paraneoplastische Syndrome. Gustav Fischer Verlag, Stuttgart

    Google Scholar 

  468. Schwartz RA (1981) Acanthosis nigricans, florid cutaneous papillomatosis and the sign of Leser-Trelat. Cutis 28: 319–334

    PubMed  CAS  Google Scholar 

  469. Schwartz RA (1994) Acanthosis nigricans. J Am Acad Dermatol31: 1–19

    Article  PubMed  CAS  Google Scholar 

  470. Stieler W, Plewig G (1987) Acanthosis nigricans maligna und Leser-Trelat-Zeichen bei Doppelmalignom von Mamma und Magen. Z Hautkrankht 62/5: 344–366

    Google Scholar 

  471. Weishaar E, Bonnekoh B, Franke I, Gollnick H (2001) Erfolgreiche symptomatische Tarazotentherapie der juvenilen Acanthosis nigricans vom familiär adipositasassoziierten Typ bei Insulinresistenz. Hautarzt 52: 499–503

    Article  Google Scholar 

  472. Wolff H (2001) Kutane Paraneoplasien. Hautarzt 52: 159–172

    Article  PubMed  CAS  Google Scholar 

  473. Yeh JS, Munn SE, Plunkett TA, Harper PG, Hopster DJ, Vivier WA du (2000) Coexistence of acanthosis nigricans and the sign of Leser-Trelat in a patient with gastric adenocarcinoma: a case report and literature review. J Am Acad Dermatol42: 357–362

    Article  PubMed  CAS  Google Scholar 

  474. Bell HK, Farrar CW, Curley RK (2001) Papu1ar acantho1ytic dyskeratosis of the vulva. Clin Exp Dermatol 26/5: 386–388

    Article  Google Scholar 

  475. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  476. Böhm I (1996) Dyskeratosis follicularis Darier (ICD Q 28.8). Therapeutische Trends und Leitlinien. Dtsch Dermatologe 44: 794

    Google Scholar 

  477. Burge S (1994) Darier's disease-the clinical features and pathogenesis. Clin Exp Dermatoll9/3: 193–205

    Article  Google Scholar 

  478. Burge S (1999) Management of Darier's disease. Clin Exp Dermatol 24/2: 53–56

    Article  Google Scholar 

  479. Leverkus M, Rose C, Bröcker EB, Hamm H (1999) Intertriginöse akantholytische Dyskeratose. Abortive Form eines Morbus Darier oder eigene klinische Entität? Hautarzt 50/10: 733–738

    Article  Google Scholar 

  480. Mailänder W, Stieler W, Stadler R (1991) Ausgedehnte Kopfhautbeteiligung bei Morbus Darier. Aktuel Dermatol17: 284–286

    Google Scholar 

  481. McMillan JR, Shimizu H (2001) Desmosomes: structure and function in normal and diseased epidermis. J Dermatol28/6: 291–298

    Google Scholar 

  482. Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  483. Sakuntabhai A, Ruiz-Perez V, Carter S et al. (1999) Mutations in ATP2A2, encoding a Ca2 + pump, cause Darier disease. Nat Genet 21/3: 271–277

    Google Scholar 

  484. Schuhmachers G, Vogt HJ (1992) Familiäre Dyskeratosis follicularis. Dtsch Dermatologe 1: 53–60

    Google Scholar 

  485. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  486. Burge SM, Millard PR, Wojnarowska F (1991) HaileyHailey disease: a widespread abnormality of ceH adhesion. Br J Dermatol 124/4: 329–332

    Article  Google Scholar 

  487. Burge SM (1992) Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol 126: 275–282

    Article  PubMed  CAS  Google Scholar 

  488. Christian MM, Moy RL (1999) Treatment of HaileyHailey disease (or benign familial pemphigus) using short pulsed and short dweH time carbon dioxide lasers. Dermatol Surg 25/8: 661–663

    Article  Google Scholar 

  489. Ganter G (1998) Lokale Kortikosteroidtherapie des Pemphigus chronicus benignus familiaris (PCBF) M.Hailey-Hailey. Akt Dermatol24: 271–274

    Google Scholar 

  490. Gschnait Fr (1973) Pemphigus familiaris chronicus benignus (Hailey-Hailey). Hautarzt 24: 243–247

    PubMed  CAS  Google Scholar 

  491. Hailey H, Hailey H (1939) Familial benign chronic pemphigus. Arch Dermatol Syph (Chic) 39: 679–685

    Google Scholar 

  492. Hamm H, Metze D, Bröcker EB (1994) Hailey-Hailey disease. Eradication by dermabrasion. Arch Dermatol 130: 1143–1149

    Article  PubMed  CAS  Google Scholar 

  493. Ikeda S et al. (1993) Successful management of HaileyHailey disease with potent topical steroid ointment. J Dermatol Sei 5: 205–211

    Article  CAS  Google Scholar 

  494. Kirtschig G, Gieler U, Happle R (1993) Treatment of Hailey-Hailey disease by dermabrasion. J Am Acad Dermatol 30: 784–786

    Article  Google Scholar 

  495. Korge BP et al. (1995) Morbus Hailey-Hailey: Topische Behandlung mit Calcipotriol. Z Hautkrankht 12: 910–912

    Google Scholar 

  496. Langenberg A, Berger TG, Cardelli M, Rodman OG, Estes S, Barron DR (1992) Genital benign chronic pemphigus (Hailey-Hailey disease) presenting as condylomas. J Am Acad Dermato126/6: 951–955

    Article  Google Scholar 

  497. Menz P, Jackson IT, Connolly S (1987) Surgical control of Hailey-Hailey disease. Br J Plast Surg 40/6: 557–561

    Article  Google Scholar 

  498. Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  499. Richard G, Linse R, Harth W (1993) Morbus HaileyHailey. Früherfassung von Merkmalsträgern durch einen UV-Provokationstest-klinische Relevanz der Methode. Hautarzt 44: 376–379

    PubMed  CAS  Google Scholar 

  500. Schirren H, Schirren CG, Schlupen EM, Volkenandt M, Kind P (1995) Exazerbation eines Morbus Hailey-Hailey durch Infektion mit Herpes-simplex-Virus. Hautarzt 46/7: 494–497

    Article  Google Scholar 

  501. Sudbrak R, Brown J, Dobson-Stone C et al. (2000) Hailey-Hailey disease is caused by mutations inATP2Cl encoding a novel Ca(2 +) pump. Hum Mol Genet 9/: 1131–1140

    Article  Google Scholar 

  502. Teikemeier G, Stein E (1996) Kontrollierte Dermabrasion mit einem neuartigen Erbium-YAG-Lasersystem. Hautarzt 47: 530–532

    Article  PubMed  CAS  Google Scholar 

  503. Anzai S, Takeo N, Yamaguchi T et al. (1999) Squamous cell carcinoma in a renal transplant recipient with linear porokeratosis. J Dermatol 26/4: 244–247

    Google Scholar 

  504. Bacharach-Buhles M et al. (1990) Porokeratosis Mibelli gigantea. Hautarzt 41: 633–635

    PubMed  CAS  Google Scholar 

  505. Cort DF, Abdel-Aziz AM (1972) Epithelioma arising in porokeratosis of Mibelli. Br J Plast Surg 25: 318–328

    Article  PubMed  CAS  Google Scholar 

  506. Coskey RJ, Mehregan A (1975) Bowen disease associated with porokeratosis of Mibelli. Arch Dermatol 111: 1480–1481

    Article  PubMed  CAS  Google Scholar 

  507. Ehlers G, Rothe A (1971) Porokeratosis Mibelli mit multiplen Praecancerosen und Plattenepithelcarcinomen. Hautarzt 22: 68–73

    PubMed  CAS  Google Scholar 

  508. Götz A, Kopera D, Wach F et al. (1999) Porokeratosis Mibelli gigantea. Fallbericht und Literaturübersicht. Hautarzt 50: 435–438

    Article  PubMed  Google Scholar 

  509. Hsu WT et al. (1992) Cutaneous T-celllymphoma with porokeratosis-like lesious. J Am Acad Dermatol 27: 327–330

    Article  PubMed  CAS  Google Scholar 

  510. Kanitakis J, Euvrard S, Faure M, Claudy A (1998) Porokeratosis and immunosuppression. Eur J Dermatol8/7: 459–465

    Google Scholar 

  511. Koch P et al. (1995) Disseminierte superfizielle Porokeratose, ortikosteroidtherapie und Immunsuppression. Hautkrankht 11: 822–826

    Google Scholar 

  512. Lucker GPH et al.(1995) An unusual case of porokeratosis involving the natal cleft: porokeratosis ptychotropica? Br J Dermatol132: 150–151

    Article  PubMed  CAS  Google Scholar 

  513. Merkle T et al. (1992) Reticulate porokeratosis: Successful treatment with COz-Laser vaporization. Clin Exp Dermatol17: 178–181

    Article  PubMed  CAS  Google Scholar 

  514. Mibelli V (1893) Contribution allo studio della ipercheratosi dei canali sudoriferi. G Ital Mal Venerol 28: 313–355

    Google Scholar 

  515. Mikhail GR, Wertheimer GW (1968) Clinical variants of porokeratosis (Mibelli). Arch Dermatol 98: 124–131

    Article  PubMed  CAS  Google Scholar 

  516. Morton CA et al. (1995) Porokeratosis and Crohn's disease. J Am Acad Dermatol 32: 894–897

    Article  PubMed  CAS  Google Scholar 

  517. Oberste-Lehn H, Moll B (1968) Porokeratosis Mibelli und Stachelzellcarcinom. Hautarzt 19: 399–403

    PubMed  CAS  Google Scholar 

  518. Otsuka F et al. (1991) Porokeratosis and malignant skin tumors. J Cancer Res Clin Oncol117: 55–60

    Article  PubMed  CAS  Google Scholar 

  519. Rabbin PE, Baldwin HE (1993) Treatment ofporokeratosis of Mibelli with COz-Iaser vaporization versus surgical excision with splitthickness skin graft. A comparison. J Dermatol Surg Oncol 19: 199–202

    PubMed  CAS  Google Scholar 

  520. Respighi E (1893) Di unna ipercheratosi non ancora discritta. G Hal Mal Venerol 28: 356–386

    Google Scholar 

  521. Rodriguez EA, Jakubowicz S, Chinchilla DA, Carril A, Viglioglia PA (1996) Porokeratosis of Mibelli and HIV-Infection. Int J Dermatol 35/6: 402–404

    Article  Google Scholar 

  522. Sasson M, Krain AD (1996) Porokeratosis and cutaneous malignancy. A review. Dermatol Surg 22/4: 339–342

    Article  Google Scholar 

  523. Schamroth JM, Zlotogorski A, Gilead L (1997) Porokeratosis of Mibelli. Overview and review of the literature. Acta Derm Venereol 77/3: 207–213

    Google Scholar 

  524. Schmiedeberg S von et al. (1995) Das Spektrum der Porokeratosis Mibelli. Z Hautkrankht 4: 289–292

    Google Scholar 

  525. Stone N, Ratnavel R, Wilkinson JD (1999) Bilateral perianal inflammatory verrucous porokeratosis (Porokeratosis ptychtropica). Br J Dermatol140/3: 553–555

    Article  Google Scholar 

  526. Torras H et al. (1981) Porokeratosis Mibelli gigantea. Ann Dermatol Venerol108: 477–478

    CAS  Google Scholar 

  527. Webster GF (2001) Are porokeratoses an infection? Arch Dermatol137/5: 665

    Google Scholar 

  528. Wurth PB, Klaus MV (1992) Porokeratosis of Mibelli following heart transplant. Int J Dermatol31: 52–54

    Article  Google Scholar 

  529. Zenarola P et al. (1993) Exacerbation of porokeratosis: a sign of immunodepression. J Am Acad Dermatol 29: 1035–1036

    Article  PubMed  CAS  Google Scholar 

  530. Andreßen C, Henseler T (1982) Erblichkeit der Psoriasis. Hautarzt 33: 214

    PubMed  Google Scholar 

  531. Böhringer D, Stein E (1978) Saalmannlampen-Bestrahlung der Psoriasis-Ein bedeutender Fortschritt im Urteil der Patienten. Dtsch Dermatologe 26: 2l–26

    Google Scholar 

  532. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Autl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  533. Costello P, FitzGerald O (2001) Disease mechanisms in psoriasis and psoriatic arthritis. Curr Rheumatol Rep 3/5: 419–427

    Article  Google Scholar 

  534. Disch R (1995) Klinik und Therapie der Psoriasis. TW Dermatologie KOMPAKT, 4–8

    Google Scholar 

  535. Farber EM, Nall L (1992) Perianal and intergluteal psoriasis. Cutis 50/5: 336–338

    Google Scholar 

  536. Herbst RA, Hoch O, Kapp A, Weiss J (2000) Guttate psoriasis triggered by perianal streptococcal dermatitis in a four-year-old boy. J Am Acad Dermatol 42/5: 885–887

    Article  Google Scholar 

  537. Highton A, Quell J (1995) Calcipotriene ointment 0,005 % for psoriasis: a safety and efficacy study. J Am Acad Dermatol 32: 67–72

    Article  PubMed  CAS  Google Scholar 

  538. Kerscher M et al. (1993) Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB. Lancet 342:923

    Article  PubMed  CAS  Google Scholar 

  539. Kienbaum S et al. (1995) Intertriginöse Psoriasis: Therapie mit Calcipotriol. Z Hautkrankht 10: 764–766

    Google Scholar 

  540. Kirby B, Griffiths CE (2001) Psoriasis: the future. Br J Dermatol144 (Suppl 58): 37–43

    PubMed  CAS  Google Scholar 

  541. Lebwohl M, Ali S (2001) Treatment of Psoriasis. Part 2: Topical therapy and phototherapy. J Am Acad Dermatol. 45/4: 487–498

    Article  Google Scholar 

  542. Lebwohl M, Ali S (2001) Treatment of psoriasis. Part 2: Systemic therapies. J Am Acad Dermatol 45/4: 649–661

    Article  Google Scholar 

  543. Lehmann P, Ruzicka T (1996) Neue Entwicklungen in der Psoriasistherapie. Dtsch Arztbl48: A–3188–A–3193

    Google Scholar 

  544. Lomholt G (1963) Psoriasis. GEC. GAD Copenhagen

    Google Scholar 

  545. Mauss J (1978) Die perianale Psoriasis-ein verlässlicher Befund bei der Differentialdiagnose der Schuppenflechte. Z Hautkr 53/9: 303–304

    Google Scholar 

  546. Meisel CW (1996) Topische Therapie der leichten bis mittelschweren Psoriasis vulgaris. Dtsch Dermatologe 44: 1132–1135

    Google Scholar 

  547. Michalowski R (1983) Erythrokeratodermia periorificialis mit Akrenbeteiligung. Der Hautarzt34:465–467

    CAS  Google Scholar 

  548. Schaller J, Metz K, Schmidt U, Kunze J (1996) Kutane Malakoplakie bei einem Patienten mit Psoriasis vulgaris. Hautarzt 47/10: 763–766

    Article  Google Scholar 

  549. Stein E (1977) Selektiertes UV-Licht gegen Psoriasis-Fortschritt durch Verzicht auf den Photosensibilisator. Ärztl Praxis 63: 2741–2742

    Google Scholar 

  550. Stein E, Böhringer D (1979) UV-Bestrahlungsgeräte. Arzt Wirtschaft 20: 31–40

    Google Scholar 

  551. Steinmeyer K, Grundmann-Kollmann M, Podda M, Kaufmann R (2001) Creme-PUVA-Photochemotherapie bei chronisch stationärer Psoriasis vulgaris. Hautarzt 52: 885–887

    Article  PubMed  CAS  Google Scholar 

  552. Bastiaens MT, Zwan NV, Verschueren GL, Stoof TJ, Nieboer C (1994) Three cases of pemphigus vegetans: induction by enalapril-association with internal malignancy. Int J Dermatol33/3: 168–171

    Google Scholar 

  553. Civatte A (1943) III. Structure histologique de la bulle des pemphigus vrais. Ann Derm Syph (Paris) 8/3: 16

    Google Scholar 

  554. Gerharz M, Stadler R (1987) Pemphigus vegetans vom Typ Hallopeau. Hautarzt 38: 371–374

    PubMed  CAS  Google Scholar 

  555. Guerra-Rodrigo F, Cardoso JPM (1971) Pemphigus vegetans: Immunfluorescent and ultrastructural studies in a patient. Arch Dermatol 104: 412–419

    Article  PubMed  CAS  Google Scholar 

  556. Heaphy MR, Tucker SB, Winkelmann RK (1976) Benign papular acantholytic dermatosis. Arch Dermatol 112:814

    Article  PubMed  CAS  Google Scholar 

  557. Jansen T, Messer G, Meurer M, Plewig G (2001) Pemphigus vegetans. Eine historische Betrachtung. Hautarzt 52:504–509

    Article  PubMed  CAS  Google Scholar 

  558. Lateef A, Packles MR, White SM, Don PC, Weinberg JM (1999) Pemphigus vegetans in association with human immunodeficiency virus. Int J Dermatol 38/10: 778–781

    Article  Google Scholar 

  559. Schmidt E, Bröcker E-B, Zillikens D (2000) Pemphigus. Verlust des desmosomalen Zell-Zell-Kontaktes. Hautarzt 51: 309–318

    Article  PubMed  CAS  Google Scholar 

  560. Wong KT, Wong KK (1994) A case of acantholytic dermatosis of the vulva with features of pemphigus vegetans. J Cutan Pathol2115:453–456

    Article  Google Scholar 

  561. Bang D, Lee JH, Lee ES et al. (2001) Epidemiologie and clinical survey of Behçet's disease in Korea: the first multicenter-study. J Korean Med Sci 16/5: 615–618

    Google Scholar 

  562. Behçet H (1937) Über rezidivierende, aphthöse, durch einen Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105: 1152–1157

    Google Scholar 

  563. Bousvaros A, Mueller B (2001) Thalidomide in gastrointestinal disorders. Drugs 61/6: 777–787

    Article  Google Scholar 

  564. Bratzke B, Zouboulis ChC, Kurz K, Wyrobisch W, Hoffmann F, Orfanos CE (1990) Therapie des Adamantiades-Behçet-Syndroms. Zentralbl Haut 157: 960–961

    Google Scholar 

  565. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Autl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  566. Christoph R (1993) Morbus Behçet: wie abgrenzen gegen M. Crohn? Ärztl Praxis 96:10

    Google Scholar 

  567. Diaz-Llopis M, Cervera M, Menezo JL (1990) Cyclosporin treatment of Behçet's disease: a long-term study. Curr Eye Res 9 [Suppl]: 17–23

    Article  PubMed  Google Scholar 

  568. Djawari D (1981) Benigne orale Aphthosis und Morbus Behçet-Epidemiologie und genetische Aspekte. Der Hautarzt (Suppl V) 32:298–301

    Google Scholar 

  569. Ehrlich GE (1999) Behçet's disease: an update. ComprTher 25/4: 216–220

    Google Scholar 

  570. Empey DW (1972) Rectal and colonic ulceration in Behçet's disease. Br J Surg 59: 173–178

    Article  PubMed  CAS  Google Scholar 

  571. Ferguson MM, Wray D, Carmichael HA, Russell RI, Lee FD (1980) Coeliac disease assoeiated with recurrent aphthae. Gut 21: 223–22

    Article  PubMed  CAS  Google Scholar 

  572. Fierlbeck G, Rassner G (1990) Morbus Behçet: Therapie mit rekombinantem Interferon gamma. Aktuel Dermatol 16: 226–230

    Google Scholar 

  573. Fierlbeck G, Rassner G (1991) Interferon gamma als Langzeittherapeutikum bei Morbus Behçet. Dermatologie 5:14

    Google Scholar 

  574. Hamuryudan V, Yurdakul S, Rosenkaimer F, Yaziei H (1991) Inefficacy of topical alpha interferon in the treatment of oral ulcers of Behçet's syndrome: a randomized, double blind trial. Br J Rheumatol 30: 395–396

    Article  PubMed  CAS  Google Scholar 

  575. Hornstein OP (1981) Orale Aphthosen und Morbus Behçet-Historische Vorbemerkungen und neue nosologische Konzepte. Hautarzt (Suppl V) 32: 297–298

    Google Scholar 

  576. International Study Group for Behçet's disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335: 1078–1080

    Google Scholar 

  577. Jorizzo JL, White WL, Wise CM et al. (1991) Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteriitis nodosa and Behçet's disease. J Am Acad Dermatol 24: 973–978

    Article  PubMed  CAS  Google Scholar 

  578. Jung RT, Chalmin TM, Joysey VC (1978) HLA in Behçet's disease. Lancet 2: 694

    Google Scholar 

  579. Kaklamani VG, Kaklamanis PG (2001) Treatment of Behçet's disease-an update. Semin Arthritis Rheum 30/5: 299–312

    Article  Google Scholar 

  580. Kurtz MD (1976) Colonoscopie diagnosis of nonspecific ulcer of the colon. Gastrointest Endosc 23: 90

    Article  PubMed  CAS  Google Scholar 

  581. Larson H (1990) Treatment of severe colitis in Behlfet's syndrome with thalidomide. J Intern Med 228:405–407

    Article  Google Scholar 

  582. Lebwohl O, Forde KA, Berdon WE (1977) Ulcerative esophagitis and colitis in a pediatrie patient with Behlfet's syndrome. Am J Gastroenterol 68: 550–554

    PubMed  CAS  Google Scholar 

  583. Lehner T, Barnes CG (1980) Behlfet's syndrome: Clinical and immunologieal features. Academie Press, New York

    Google Scholar 

  584. Moraes M, Russo G (2001) Thalidomide and its dermatologie uses. Am J Med Sci 321/5: 321–326

    Article  Google Scholar 

  585. Nussenblatt RB, Palestine AG, Rook AH, Scher I, Wacker WB, Gery I (1983) Treatment of intraocular inflammatory disease with cyclosporin A. Lancet 2/8344: 235–238

    Article  Google Scholar 

  586. Onder M, Gurer MA (2000) The multiple faces of Behlfet's disease and its aetiologieal factors. J Eur Acad Dermatol Venereol1512: 126–136

    Google Scholar 

  587. Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  588. Shimizu T, Ogino T (1975) Clinieo-pathological studies on the intestinaliesions in Behlfet's disease-with special reference to entero-Behlfet's syndrome. Stomach Intestine 10: 1593–1598

    Google Scholar 

  589. Simsek H, Dundar S, Telatar H (1991) Treatment of Behlfet's disease with indomethacin. Int J Dermatol 30: 54–57

    Article  PubMed  CAS  Google Scholar 

  590. Sloper CM, Powell RJ, Dua HS (1999) Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophtalmology 106/4: 723–728

    Article  Google Scholar 

  591. Sobel JD, Haim S, Shafrir A, Gellei B (1973) Cutaneous hyperreactivity in Behlfet's disease. Dermatologiea 146:350–356

    Article  CAS  Google Scholar 

  592. Stadler R et al. (1987) Morbus Behlfet und exogenes Interferon. Hautarzt 38: 97–100

    PubMed  CAS  Google Scholar 

  593. Sullu Y, Oge I, Erkan D, Ariturk N, Mohajeri F (1998) Cyclosporin-A therapy in severe uveitis of Behlfet's disease. Acta Ophtalmol 76/1: 96–99

    Article  Google Scholar 

  594. Takeuschi A, Hashimoto T (1988) Oral prostagiandin EI as a therapeutie modality for leg ulcers in Behlfet's disease. Int J Clin Pharmacol Res 7:283–289

    Google Scholar 

  595. Torök L, Egyedi K (1983) Behandlung von Morbus Behlfet mit Kolchizin. Hautarzt 34: 87–88

    PubMed  Google Scholar 

  596. Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL (2001) Treatment of intestinal Behlfet's syndrome with chimeric tumour necrosis factor alpha antibody. Gut 49/5: 725–728

    Article  Google Scholar 

  597. Tüzün Y, Yazici M, Pazarli H, Yalcin B, Yurdakul S, Müftüoglu A (1979) The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Behlfet's disease in Turkey. Acta Dermatovener (Stockh) 59: 77–79

    Google Scholar 

  598. Weimann C, Keitel R, Keitel W, Zimmermann Ch (1991) Das Behlfet-Syndrom. Mögliehe Differenzialdiagnose bei multisystemischer Symptomatik. Z Gesamte Inn Med 46:234–236

    PubMed  CAS  Google Scholar 

  599. Zouboulis CC, Büttner P, Djawari D et al. (1993) HLAMuster bei Morbus Adamantiades-Behlfet in Deutschland: Assoziation zum Auftreten, der klinischen Symptomatik und dem Krankheitsverlauf bei 39 Patienten. Hautarzt 44: 81–85

    PubMed  CAS  Google Scholar 

  600. Zouboulis CC, Treudler R, Orfanos CE (1993) Morbus Admantiades-Behlfet: therapeutischer Einsatz von systemischen rekombinantem Interferon-alpha-2 a. Hautarzt 44: 440–445

    PubMed  CAS  Google Scholar 

  601. Zouboulis CC, Kotter I, Djawari D et al. (1997) Epidemiologieal features of Adamantiades-Behlfet's disease in Germany and in Europe. Yonsei Med J 38/6: 411–422

    Google Scholar 

  602. Achtelik W, Wolff HH (1991) Schweißdrüsentumoren und Morbus Paget: immunhistologische Marker zur Differenzierung und Differentialdiagnose. Pathologie 12: 316–321

    CAS  Google Scholar 

  603. Arensmeier M et al. (1994) Topische Therapie des extramammären Morbus Paget. Hautarzt 45: 780–782

    Article  PubMed  CAS  Google Scholar 

  604. Arminski TC, Pollard RJ (1973) Paget's disease of the anus secundary to a malignant papillary adenoma of the rectum. Dis Colon Rectum 16: 46

    Article  PubMed  CAS  Google Scholar 

  605. Blasco T, Garcia-Armengol J, Roig JV, Garcia-Castel J (1998) Perianal Paget's disease. Coloproctology 20: 7–10

    Article  Google Scholar 

  606. Dörner A, Müller S, Dietel M (1987) Der perianale (extramammäre) Morbus Paget. Coloproctology 6: 327–330

    Google Scholar 

  607. Fligiel Z, Kaneko M (1975) Extramammary Paget's disease of the extern al ear canal in association with ceruminous gland carcinoma: a case report. Cancer 36: 1072

    Article  PubMed  CAS  Google Scholar 

  608. Furukawa F, Kashihara M, Miyauchi H, Yamabe H, Hamashimo Y, Imamura S (1984) Evaluation of carcinoembryonie antigen in extramammary Paget's disease. J Cutan Pathol 11: 558–561

    Article  PubMed  CAS  Google Scholar 

  609. Goldblum JR, Hart WR (1998) Perianal Paget's disease: a histologie and immunohistochemieal study of 11 cases with and without associated rectal adenocarcinoma. Am J Surg Pathol 22/2: 170–179

    Article  Google Scholar 

  610. Goldmann S, Ihre T, Lagerstedt U, Svensson C (1992) Perianal Paget's disease: report of five cases. Int J Colorectal Dis 7/3: 167–169

    Article  Google Scholar 

  611. Gunn A, Fox H (1971) Perianal Paget's disease. Br J Dermatol 85: 476

    Article  PubMed  CAS  Google Scholar 

  612. Heitland W (1997) Anale und perianale Tumoren. Ther Umsch 54/4: 202–204

    Google Scholar 

  613. Herzog U, Flue M von, Roche R de, Curschellas E (1993) Perianal extramammary Paget's disease. Report of two cases. Eur J Surg OncoI19/5: 469–473

    Google Scholar 

  614. Jabbar AS (2000) Perianal extramammary Paget's disease. Eur J Surg Oncol 26/6: 612–614

    Article  Google Scholar 

  615. Krahl D (1994) Östrogenrezeptor-assoziiertes Protein (p 29) und Histogenese des extramammären Morbus Paget. Z Hautkrankht 11: 764–768

    Google Scholar 

  616. Kubota K, Akasu T, Nakanishi Y, Sugihara K, Fujita S, Moriya Y (1998) Perianal Paget's disease associated with rectal carcinoma: a case report. Jpn J Clin Oncol 28/5: 347–350

    Article  Google Scholar 

  617. Lam DT, Batista O, Weiss EG, Nogueras JJ, Wexner SD (2001) Staged excision and split-thickness skin graft for circumferential perianal Paget's disease. Dis Colon Rectum 44/6: 868–870

    Article  Google Scholar 

  618. Landthaler M (1988) Extramammärer Paget: Wie kann ich helfen? Ärztl Praxis 7: 1O9

    Google Scholar 

  619. Lechner Wet al. (1987) Extramammärer Morbus Paget. Aktuel Dermatol 13: 43–46

    Google Scholar 

  620. Moll I, Moll R (1985) Cells of extramammary Paget's disease express cytokeratins different from those of epidermal cells. J Invest Dermatol 84: 3–8

    Article  PubMed  CAS  Google Scholar 

  621. Neumann R (1986) Extramammärer Morbus Paget-assoziiert mit einem Magenkarzinom. Hautarzt 37: 568–570

    PubMed  CAS  Google Scholar 

  622. Oji M, Furue M, Tamaki K (1984) Serum carcinoembryonie antigen level in Paget's disease. Br J Dermatol 110: 211–213

    Article  PubMed  CAS  Google Scholar 

  623. Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  624. Paget J (1874) One disease of the mammary areola proceeding cancer of the mammary gland. St Bart Hosp Rep 10: 87

    Google Scholar 

  625. Parmley Th, Woodruff JD, Julian CG (1975) Invasive vulvar Paget's disease. Obstet Gynecol46: 341

    PubMed  CAS  Google Scholar 

  626. Parturier-Albot M, Prevost AG, Albot G, Boigert M (1982) Les carcinomes multieentriques de la region ano-rectale. Apropos de l'association d'un epithelioma villeux de l'ampoule rectale, d'une maladie de Bowen anale et d'une maladie de Paget anale. Ann Gastroenterol Hépatol 18: 227–235

    Google Scholar 

  627. Remond B et al. (1993) Umbilical Paget's disease and prostatie carcinoma. Br J Dermatol 128: 448–450

    Article  PubMed  CAS  Google Scholar 

  628. Runfola MA, Weber TK, Rodriguez-Bigas MA, Dougherty TJ, Petrelli NJ (2000) Photodynamie therapy for residual neoplasms of the perianal skin. Dis Colon Rectum 43/4: 499–502

    Article  Google Scholar 

  629. Sarmiento JM, Wolff BG, Burgart LJ, Frizelle FA, Ilstrup DM (1997) Paget's disease of the perianal region-an aggressive disease? Dis Colon Rectum 40/10: 1187–1194

    Article  Google Scholar 

  630. Tjandra J (1988) Perianal Paget's disease: report of three cases. Dis Colon Rectum 31: 462–466

    Article  PubMed  CAS  Google Scholar 

  631. Ueki H, Kohda M (1979) Multilokulärer extramammärer Morbus Paget. Hautarzt 30: 267–270

    PubMed  CAS  Google Scholar 

  632. Webb AT (1965) Occult Paget's disease of the anus. Report of a case. Dis Colon Rectum 8: 286

    Article  Google Scholar 

  633. Whorton CM, Patterson JB (1955) Carcinoma of Moll's glands with extramammary Paget's disease of the eyelid. Cancer 8: 1009

    Article  PubMed  CAS  Google Scholar 

  634. Bank A, Christensen C (1988) Unusual manifestation of Langerhans' ceU histiocytosis. Acta Med Scand 223/5: 479–480

    Google Scholar 

  635. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Book  Google Scholar 

  636. Burgdorf WHC (1986) Malignant histiocytic infiltrates. In: Murphy GF, Mihm MC Jr (eds) Lymphoproliferative disorders of the skin. Butterworths, Boston, pp 217–255

    Google Scholar 

  637. Caputo R (1998) Text and atlas of histiocytic syndromes. Martin Dunitz, London

    Google Scholar 

  638. Cavender PA, Bennett RG (1988) Perianal eosinophilic granuloma resembling condyloma latum. Pediatr Dermatol 5/1: 50–55

    Article  Google Scholar 

  639. Favara BE, Feller AC, Pauli M et al. (1997) Contemporary classification of histiocytic dis orders (The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society) Med Pedriatr Oncol29/3: 157–166

    Article  Google Scholar 

  640. Gadner H (1999) Langerhans cell histiocytosis-still an unsolved problem? Pediatr Hematol Oncol 16/6: 489–493

    Article  Google Scholar 

  641. Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S (1994) Treatment strategy for disseminated Langerhans ceU histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 23/2: 72–80

    Article  Google Scholar 

  642. Gianotti F, Caputo R (1985) Histiozytic syndromes: A review. J Am Acad Dermatol 13: 383–404

    Article  PubMed  CAS  Google Scholar 

  643. Grundy P, Ellis R (1986) Histiocytosis X: a review of the etiology, pathology, staging and therapy. Med Pediatr Oncol 14: 45–50

    Article  PubMed  CAS  Google Scholar 

  644. Hoting E et al. (1988) Histiozytosis X.Aktuel Dermatol 14: 139–141

    Google Scholar 

  645. Kader HA, RucheHi E, Maller ES (1998) Langerhans' cell histiocytosis with stool retention caused by a perianal mass. J Pedriatr Gastroenterol Nutr 26/2: 226–228

    Article  Google Scholar 

  646. Lichtenstein (1953) Histiocytosis X: integration of eosinophilic granuloma of bones, Letterer-Siwe disease and Schuller-Christian disease as related manifestations of a single nosologic entity. Arch Pathol Lab Med 56: 84–102

    CAS  Google Scholar 

  647. Mejia R, Dano JA, Roberts R, Wiley E, Cockerell CJ, Cruz PD Jr (1997) Langerhans' cell histiocytosis in adults. J Am Acad Dermatol 37: 314–317

    Article  PubMed  CAS  Google Scholar 

  648. Nezelof C, Frileux-Herbert F, Cronier-Sachot J (1979) Disseminated histiocytosis X: analysis of prognostic factors based on a retrospective study of 50 cases. Cancer 44: 1824–1838

    Article  PubMed  CAS  Google Scholar 

  649. Snow JL, Su WP (1995) Histiocytic diseases. J Am Dermatol 33/1: 111–116

    Article  Google Scholar 

  650. Torok L, Tiszlavicz L, Somogyi T, Toth G, Tapai M (2000) Perianal ulcer as a leading symptom of paedriatric Langerhans' cell histiocytosis. Acta Derm Venereol 80/1: 49–51

    Google Scholar 

  651. Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 863

    Google Scholar 

  652. Elliot GT (1893) Adeno-cystoma intracanaliculare occuring in a naevus unius lateris. J Cut Genitourin Dis 11:168. Zit. nach Helwig EB, Hackney VC (1955)

    Google Scholar 

  653. Ishida-Yamamoto A, Sato K, Wada T, Takahashi H, Iizuka H (2001) Syringocystadenocarcinoma papilliferum: Case report and immunohistochemical comparison with its benign counterpart. J Am Acad Dermatol 45/5: 755–759

    Article  Google Scholar 

  654. Ishikowa K (1987) Syringocystadenoma papilliferum, syringadenoma papilliferum. In: Ishikowa K (ed) Adnexal tumors of the skin. Springer, Berlin Heidelberg New York, pp 96–97

    Chapter  Google Scholar 

  655. Mlitz H (1988) Syringozystadenom der Perianalregion. In: Junghans PC, Brühl W, Zenner O (Hrsg) Aktuelle Koloproktologie, Bd 5. Edition Nymphenburg, München, S 133-136

    Google Scholar 

  656. Niebauer G (1983) Naevus syringocystadenomatosus papilliferus Pinkus (hydrocystoma-WHO). In: Luger A, Gschnait F (Hrsg) Dermatologische Onkologie. Urban & Schwarzenberg, Wien München Baltimore, S 88–89

    Google Scholar 

  657. Pinkus H (1954) Life history of naevus syringadenomatosus papilliferus. Arch Dermatol 69: 305–322

    Article  CAS  Google Scholar 

  658. Pullmann H, Pfeiff B (1985) Syringocystadenoma papilliferum als Differentialdiagnose eines Unterlippencarcinoms. Hautarzt 60/4: 348–355

    Google Scholar 

  659. Rupec M, Horn MuW (1981) Benigne Tumoren der Haut. In: Korting GW (Hrsg) Dermatologie in Praxis und Klinik, Bd IV. Thieme, Stuttgart, S 40.61–40.62

    Google Scholar 

  660. Skelton HG 3rd, Smith KJ, Young D, Lupton GP (1994) Condylomata acuminatum associated with syringocystadenoma papilliferum. Am J Dermatopathol 16/6: 628–630

    Article  Google Scholar 

  661. Werther J (1913) Syringadenoma papilliferum (Naevus syringadenomatosus papilliferus). Arch Dermatol Syph (Berl) 116: 865–870

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Arzt für Dermatologie — Allergologie, Schwetzinger Straße 35, Limburgerhof, 67117, Germany

    Dr.med. Ernst Stein

Authors
  1. Dr.med. Ernst Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stein, E. (2003). Perianal lokalisierte Krankheitsbilder. In: Proktologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55594-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55594-7_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62761-3

  • Online ISBN: 978-3-642-55594-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation